Sector · data as of
Healthcare stocks: fair value, margin of safety and Wheel Score
1,120 Healthcare companies across 13 industries, the largest being Biotechnology (622), Medical - Devices (137), Drug Manufacturers - Specialty & Generic (76). 332 of the 751 with a GLS fair value (44%) trade below it; the median Wheel Score of the 705 with listed options is 45. Click a ticker for its fact sheet.
Top 10 by Wheel Score in Healthcare
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| BSX Boston Scientific Corporation | 44.14 | 65.77 | +33% | 95Prime | 8 | $64.0B |
| EXEL Exelixis, Inc. | 62.83 | 105.86 | +41% | 94Prime | 7 | $15.8B |
| GMED Globus Medical, Inc. | 78.84 | 112.94 | +30% | 92Prime | 7 | $10.6B |
| NVO Novo Nordisk A/S | 39.22 | 173.67 | +77% | 91Prime | 6 | $174.9B |
| UHS Universal Health Services, Inc. | 185.89 | 441.31 | +58% | 91Prime | 8 | $11.0B |
| CI Cigna Corporation | 298.81 | 611.26 | +51% | 90Prime | 8 | $79.0B |
| FMS Fresenius Medical Care AG & Co. KGaA | 22.13 | 66.81 | +67% | 90Prime | 8 | $11.8B |
| SNN Smith & Nephew plc | 27.88 | 37.94 | +27% | 90Prime | 8 | $11.7B |
| ZTS Zoetis Inc. | 75.34 | 95.52 | +21% | 89Prime | 7 | $31.6B |
| CAH Cardinal Health, Inc. | 253.71 | 343.24 | +26% | 88Prime | 7 | $58.7B |
All Healthcare stocks by industry
Biotechnology 622 · Drug Manufacturers - General 19 · Drug Manufacturers - Specialty & Generic 76 · Medical - Care Facilities 61 · Medical - Devices 137 · Medical - Diagnostics & Research 44 · Medical - Distribution 13 · Medical - Equipment & Services 1 · Medical - Healthcare Information Services 44 · Medical - Healthcare Plans 13 · Medical - Instruments & Supplies 45 · Medical - Pharmaceuticals 25 · Medical - Specialties 20
Biotechnology (622)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| AAPG Ascentage Pharma Group International | 14.69 | - | - | 27No options | 2 | $1.4B |
| AARD Aardvark Therapeutics, Inc. Common Stock | 3.86 | 2.06 | -87% | 10Weak | 1 | $84M |
| ABCL AbCellera Biologics Inc. | 12.68 | - | - | 45Weak | 3 | $4.1B |
| ABEO Abeona Therapeutics Inc. | 4.65 | 0.9983 | -366% | 35Weak | 2 | $265M |
| ABOS Acumen Pharmaceuticals, Inc. | 1.67 | 0.3755 | -345% | 20Weak | 2 | $121M |
| ABPO Abpro Holdings, Inc. | 0.4080 | 13.18 | +97% | 39No options | 3 | $2M |
| ABSI Absci Corporation | 8.88 | 0.0424 | -20862% | 31Weak | 4 | $1.5B |
| ABUS Arbutus Biopharma Corp | 4.29 | 6.25 | +31% | 74Good | 5 | $850M |
| ABVC ABVC BioPharma, Inc. | 0.9325 | - | - | 26Weak | 1 | $25M |
| ABVX Abivax S.A. | 92.38 | 7.19 | -1184% | 44Weak | 3 | $6.8B |
| ACAD Acadia Pharmaceuticals Inc. | 19.71 | 67.06 | +71% | 80Prime | 4 | $3.4B |
| ACET Adicet Bio, Inc. | 5.14 | 2.93 | -75% | 24Weak | 1 | $48M |
| ACHV Achieve Life Sciences, Inc. | 6.97 | 0.1198 | -5718% | 30Weak | 2 | $717M |
| ACIU AC Immune S.A. | 2.45 | - | - | 33Weak | 2 | $249M |
| ACOG Alpha Cognition Inc | 8.45 | 6.46 | -31% | 17Weak | 2 | $131M |
| ACRS Aclaris Therapeutics, Inc. | 3.49 | - | - | 40Weak | 2 | $513M |
| ACRV Acrivon Therapeutics, Inc. Common Stock | 1.76 | 0.9553 | -84% | 8No options | 1 | $75M |
| ACTU Actuate Therapeutics Inc | 0.4999 | 0.5399 | +7% | 32No options | 2 | $12M |
| ACUT Accustem Sciences Inc. | 0.1474 | - | - | 23No options | 2 | $2M |
| ACXP Acurx Pharmaceuticals, Inc. | 1.17 | 5.07 | +77% | 38No options | 2 | $7M |
| ADAG Adagene Inc. | 2.40 | - | - | 36No options | 5 | $90M |
| ADCT ADC Therapeutics S.A. | 1.49 | - | - | 32Weak | 1 | $190M |
| ADIL Adial Pharmaceuticals, Inc. | 3.14 | 7.98 | +61% | 37No options | 2 | $8M |
| ADMA ADMA Biologics, Inc. | 10.73 | 21.14 | +49% | 79Good | 6 | $2.4B |
| ADPT Adaptive Biotechnologies Corporation | 25.58 | - | - | 45Weak | 4 | $4.1B |
| ADXN Addex Therapeutics Ltd | 3.02 | 1.39 | -118% | 11No options | 2 | $4M |
| AEON AEON Biopharma, Inc. | 0.2430 | - | - | 27No options | 2 | $12M |
| AGEN Agenus Inc. | 6.68 | 56.78 | +88% | 60Fair | 6 | $302M |
| AGIO Agios Pharmaceuticals, Inc. | 32.32 | 3.68 | -778% | 36Weak | 3 | $1.9B |
| AGMB AgomAb Therapeutics N.V. American Depositary Shares | 8.33 | 1.90 | -339% | 4No options | 0 | $410M |
| AIM AIM ImmunoTech Inc. | 0.1703 | - | - | 31No options | 3 | $7M |
| AIMD Ainos, Inc. | 0.9600 | - | - | 19No options | 2 | $7M |
| AKBA Akebia Therapeutics, Inc. | 0.6955 | 3.13 | +78% | 45Weak | 3 | $193M |
| AKTS Aktis Oncology, Inc. | 16.01 | 2.99 | -436% | 28Weak | 2 | $860M |
| AKTX Akari Therapeutics, Plc | 8.84 | 8.58 | -3% | 28Weak | 2 | $20M |
| ALDX Aldeyra The | 0.7373 | 0.9053 | +19% | 45Weak | 2 | $44M |
| ALEC Alector, Inc. | 1.91 | - | - | 37Weak | 2 | $213M |
| ALGS Aligos Therapeutics, Inc. | 5.39 | 0.1520 | -3446% | 12No options | 2 | $34M |
| ALLO Allogene Therapeutics, Inc. | 1.34 | - | - | 42Weak | 4 | $463M |
| ALLR Allarity Therapeutics, Inc. | 0.8327 | 1.15 | +28% | 38No options | 1 | $13M |
| ALMR Alamar Biosciences, Inc. | 27.42 | 20.52 | -34% | 20No options | 0 | $1.9B |
| ALMS Alumis Inc. | 6.31 | 0.8880 | -611% | 37Weak | 2 | $817M |
| ALNY Alnylam Pharmaceuticals, Inc. | 234.03 | 173.82 | -35% | 59Fair | 6 | $31.3B |
| ALPS Alps Group Inc | 0.3390 | 0.0967 | -251% | 15No options | 3 | $56M |
| ALT Altimmune, Inc. | 2.36 | 0.0808 | -2821% | 34Weak | 2 | $459M |
| ALXO ALX Oncology Holdings Inc. | 1.00 | 0.1291 | -674% | 25Weak | 2 | $138M |
| ALZN Alzamend Neuro Inc | 1.28 | - | - | 23No options | 1 | $6M |
| AMLX Amylyx Pharmaceuticals, Inc. | 27.65 | 2.30 | -1102% | 42Weak | 3 | $3.5B |
| AMPE Ampio Pharmaceuticals, Inc. | 0.1831 | 4.89 | +96% | 33No options | 3 | $208K |
| ANAB AnaptysBio, Inc. | 48.71 | 119.69 | +59% | 66Good | 5 | $1.5B |
| ANEB Anebulo Pharmaceuticals, Inc. | 0.3100 | 0.3396 | +9% | 26No options | 1 | $13M |
| ANIX Anixa Biosciences, Inc. | 2.78 | 0.0273 | -10072% | 19Weak | 2 | $97M |
| ANL Adlai Nortye Ltd. | 12.09 | 0.4209 | -2773% | 23No options | 3 | $642M |
| ANNX Annexon, Inc. | 3.60 | 0.7891 | -356% | 24Weak | 1 | $590M |
| ANRO Alto Neuroscience, Inc. | 22.62 | 5.91 | -283% | 31Weak | 2 | $888M |
| ANTX AN2 Therapeutics, Inc. | 3.60 | 0.5937 | -506% | 24Weak | 1 | $136M |
| ANVS Annovis Bio, Inc. | 1.05 | 0.8366 | -26% | 22Weak | 1 | $45M |
| APLM Apollomics, Inc. | 21.00 | - | - | 28No options | 3 | $61M |
| APRE Aprea Therapeutics, Inc. | 0.6176 | 2.14 | +71% | 38No options | 3 | $8M |
| APUS Apimeds Pharmaceuticals US, Inc | 4.39 | - | - | 23No options | 1 | $7M |
| APVO Aptevo Therapeutics Inc. | 1.70 | 5,120.14 | +100% | 33No options | 1 | $4M |
| ARCT Arcturus Therapeutics Holdings Inc. | 11.27 | - | - | 35Weak | 1 | $320M |
| ARDX Ardelyx, Inc. | 3.27 | - | - | 45Weak | 2 | $814M |
| ARGX argenx SE | 846.27 | 796.62 | -6% | 65Good | 5 | $52.3B |
| ARMP Armata Pharmaceuticals, Inc. | 3.09 | - | - | 29Weak | 2 | $115M |
| ARQT Arcutis Biotherapeutics, Inc. | 29.10 | 7.81 | -273% | 54Fair | 7 | $3.7B |
| ARTL Artelo Biosciences, Inc. | 2.74 | - | - | 25No options | 2 | $10M |
| ARTV Artiva Biotherapeutics, Inc. | 6.06 | 0.6593 | -819% | 20Weak | 1 | $296M |
| ARVN Arvinas, Inc. | 7.16 | 3.61 | -99% | 44Weak | 6 | $462M |
| ARWR Arrowhead Pharmaceuticals, Inc. | 58.50 | - | - | 45Weak | 3 | $8.3B |
| ASMB Assembly Biosciences, Inc. | 20.57 | - | - | 45Weak | 2 | $419M |
| ASND Ascendis Pharma A/S | 226.62 | 267.55 | +15% | 70Good | 6 | $14.1B |
| ATHE Alterity Therapeutics Limited | 2.72 | 1.73 | -57% | 12No options | 2 | $46M |
| ATNM Actinium Pharmaceuticals, Inc. | 1.06 | 3.20 | +67% | 49Weak | 4 | $33M |
| ATOS Atossa Therapeutics, Inc. | 2.65 | 4.35 | +39% | 45Weak | 1 | $26M |
| ATRA Atara Biotherapeutics, Inc. | 9.65 | - | - | 25No options | 1 | $97M |
| ATTO Attovia Therapeutics, Inc. | 14.78 | 0.9548 | -1448% | 21No options | 0 | $675M |
| ATXI Avenue Therapeutics, Inc. | 0.4300 | 15.31 | +97% | 36No options | 1 | $1M |
| ATYR aTyr Pharma, Inc. | 0.1838 | - | - | 38Weak | 2 | $18M |
| AUPH Aurinia Pharmaceuticals Inc. | 16.73 | 58.34 | +71% | 81Prime | 6 | $2.2B |
| AURA Aura Biosciences, Inc. | 6.34 | 0.6743 | -840% | 30Weak | 2 | $657M |
| AURX Nuo Therapeutics, Inc. | 1.28 | - | - | 25No options | 2 | $62M |
| AUTL Autolus Therapeutics plc | 1.72 | - | - | 37Weak | 3 | $458M |
| AVBP ArriVent BioPharma, Inc. | 16.79 | 1.05 | -1504% | 27Weak | 2 | $828M |
| AVIR Atea Pharmaceuticals, Inc. | 4.53 | 1.01 | -346% | 30Weak | 2 | $363M |
| AVLN Avalyn Pharma Inc. Common Stock | 24.64 | 1.14 | -2064% | 29Weak | 0 | $1.1B |
| AVTX Avalo Therapeutics, Inc. | 12.01 | 0.9861 | -1118% | 26Weak | 2 | $644M |
| AVXL Anavex Life Sciences Corp. | 1.48 | 1.17 | -27% | 24Weak | 1 | $137M |
| AXSM Axsome Therapeutics, Inc. | 161.79 | - | - | 45Weak | 3 | $8.5B |
| BBIO BridgeBio Pharma, Inc. | 67.13 | - | - | 45Weak | 3 | $13.1B |
| BBLG Bone Biologics Corporation | 0.3876 | 4.22 | +91% | 36No options | 1 | $1M |
| BBOT BridgeBio Oncology Therapeutics Inc. | 2.95 | 11.88 | +75% | 36No options | 0 | $237M |
| BCAX Bicara Therapeutics Inc. Common Stock | 17.62 | 1.60 | -1000% | 32Weak | 1 | $1.2B |
| BCDA BioCardia, Inc. | 0.9385 | 0.2082 | -351% | 13No options | 1 | $14M |
| BCLI Brainstorm Cell Therapeutics Inc. | 0.8000 | - | - | 21No options | 1 | $9M |
| BCRX BioCryst Pharmaceuticals, Inc. | 8.02 | 28.41 | +72% | 45Weak | 5 | $2.0B |
| BCTX BriaCell Therapeutics Corp. | 3.77 | 4.14 | +9% | 29No options | 2 | $33M |
| BCTXZ BriaCell Therapeutics Corp. Warrant | 0.1565 | 19.13 | +99% | 37No options | 2 | $295K |
| BCYC Bicycle Therapeutics plc | 3.60 | - | - | 45Weak | 3 | $252M |
| BDRX Biodexa Pharmaceuticals Plc | 0.4314 | 515.53 | +100% | 39No options | 1 | $322K |
| BDTX Black Diamond Therapeutics, Inc. | 1.74 | 11.06 | +84% | 42Weak | 1 | $100M |
| BEAM Beam Therapeutics Inc. | 24.73 | - | - | 45Weak | 2 | $2.6B |
| BHVN Biohaven Ltd. | 11.43 | - | - | 41Weak | 2 | $1.7B |
| BIOA BioAge Labs Inc. | 5.35 | 8.75 | +39% | 45Weak | 3 | $201M |
| BIVI BioVie Inc. | 1.13 | 1,200,941.90 | +100% | 39No options | 2 | $10M |
| BLRX BioLineRx Ltd. | 2.05 | 0.1816 | -1029% | 15Weak | 1 | $10M |
| BLSM BlossomHill Therapeutics, Inc. | 14.98 | 3.85 | -289% | 12No options | 0 | $436M |
| BLTE Belite Bio, Inc | 152.62 | 10.53 | -1349% | 21No options | 2 | $6.1B |
| BMEA Biomea Fusion, Inc. | 0.8364 | 0.9797 | +15% | 40Weak | 0 | $60M |
| BMRN BioMarin Pharmaceutical Inc. | 56.05 | 24.83 | -126% | 59Fair | 4 | $10.8B |
| BNTC Benitec Biopharma Inc. | 8.46 | 2.68 | -216% | 17Weak | 1 | $295M |
| BNTX BioNTech SE | 90.20 | 49.55 | -82% | 45Weak | 2 | $22.6B |
| BOLD Boundless Bio, Inc. | 2.35 | - | - | 26No options | 1 | $53M |
| BOLT Bolt Biotherapeutics, Inc. | 4.24 | - | - | 27No options | 2 | $8M |
| BRTX BioRestorative Therapies, Inc. | 1.46 | - | - | 26No options | 2 | $2M |
| BSEM BioStem Technologies, Inc. | 2.04 | - | - | 26No options | 2 | $38M |
| BYSI BeyondSpring Inc. | 0.5819 | 0.1764 | -230% | 15Weak | 1 | $24M |
| CABA Cabaletta Bio, Inc. | 1.55 | 0.4921 | -215% | 18Weak | 2 | $263M |
| CADL Candel Therapeutics, Inc. | 8.91 | 2.20 | -304% | 23Weak | 2 | $682M |
| CAI Caris Life Sciences, Inc. | 31.76 | 18.13 | -75% | 48Weak | 5 | $9.0B |
| CALC CalciMedica, Inc. | 1.08 | 0.0003 | -422318% | 13No options | 3 | $3M |
| CAMP CAMP4 Therapeutics Corporation | 3.45 | - | - | 26No options | 1 | $216M |
| CANF Can-Fite BioPharma Ltd. | 1.85 | - | - | 30No options | 3 | $2M |
| CAPR Capricor Therapeutics, Inc. | 7.27 | 5.78 | -26% | 28Weak | 2 | $421M |
| CBIO Crescent Biopharma, Inc. | 12.48 | 20.78 | +40% | 45Weak | 3 | $464M |
| CBUS Cibus, Inc. | 1.29 | - | - | 29Weak | 3 | $99M |
| CCCC C4 Therapeutics, Inc. | 2.78 | - | - | 42Weak | 3 | $342M |
| CDIO Cardio Diagnostics Holdings, Inc. | 1.76 | 2.25 | +22% | 32No options | 1 | $5M |
| CDT CDT Equity Inc. | 0.2090 | 5,315.64 | +100% | 39No options | 7 | $235K |
| CDXS Codexis, Inc. | 1.36 | - | - | 32Weak | 3 | $149M |
| CELC Celcuity Inc. | 60.30 | - | - | 45Weak | 2 | $3.0B |
| CELU Celularity Inc. | 1.33 | - | - | 31Weak | 2 | $43M |
| CELZ Creative Medical Technology Holdings, Inc. | 0.8178 | 2.94 | +72% | 34No options | 1 | $2M |
| CGEM Cullinan Therapeutics, Inc. | 14.00 | 1.44 | -874% | 22Weak | 1 | $860M |
| CGEN Compugen Ltd. | 2.08 | 11.43 | +82% | 57Fair | 5 | $197M |
| CGON CG Oncology Inc. | 61.86 | - | - | 45Weak | 3 | $5.5B |
| CGTX Cognition Therapeutics, Inc. | 0.7326 | 0.6038 | -21% | 17No options | 1 | $70M |
| CHRS Coherus Oncology, Inc. | 1.07 | - | - | 36Weak | 2 | $165M |
| CING Cingulate Inc. | 4.39 | 0.0505 | -8592% | 24Weak | 2 | $64M |
| CLCS Cell Source, Inc. | 0.4649 | - | - | 26No options | 2 | $32M |
| CLDI Calidi Biotherapeutics, Inc. | 0.8701 | 9.22 | +91% | 33No options | 1 | $2M |
| CLDX Celldex Therapeutics, Inc. | 28.93 | 0.2352 | -12198% | 41Weak | 2 | $2.3B |
| CLGN CollPlant Biotechnologies Ltd. | 3.68 | - | - | 30Weak | 1 | $5M |
| CLLS Cellectis S.A. | 1.11 | - | - | 25Weak | 2 | $111M |
| CLNN Clene Inc. | 3.31 | - | - | 30Weak | 2 | $47M |
| CLRB Cellectar Biosciences, Inc. | 1.19 | 4.39 | +73% | 39No options | 2 | $11M |
| CLYM Climb Bio, Inc. | 10.91 | 0.4867 | -2142% | 23Weak | 2 | $627M |
| CMMB Chemomab Therapeutics Ltd. | 1.29 | 1.56 | +17% | 28No options | 0 | $8M |
| CMND Clearmind Medicine Inc. | 6.42 | 7.99 | +20% | 31No options | 1 | $3M |
| CMPS COMPASS Pathways plc | 11.62 | 1.38 | -743% | 31Weak | 1 | $1.6B |
| CMPX Compass Therapeutics, Inc. | 0.8967 | 0.1228 | -630% | 26Weak | 3 | $161M |
| CNSP CNS Pharmaceuticals, Inc. | 5.18 | 7.71 | +33% | 35No options | 1 | $8M |
| CNTB Connect Biopharma Holdings Limited | 0.9062 | 0.6535 | -39% | 19Weak | 1 | $57M |
| CNTN Canton Strategic Holdings Inc | 1.87 | 0.5011 | -273% | 22No options | 4 | $149M |
| CNTX Context Therapeutics Inc. | 0.2405 | 0.6686 | +64% | 39No options | 2 | $22M |
| COAG Hemab Therapeutics Holdings, Inc. Common Stock | 32.52 | 3.06 | -962% | 11No options | 0 | $1.5B |
| COCP Cocrystal Pharma, Inc. | 1.03 | 0.4743 | -117% | 13No options | 3 | $20M |
| CODX Co-Diagnostics, Inc. | 0.7151 | 7.44 | +90% | 34No options | 2 | $5M |
| COGT Cogent Biosciences, Inc. | 29.51 | 0.3102 | -9415% | 41Weak | 2 | $5.1B |
| COYA Coya Therapeutics, Inc. | 4.34 | 4.59 | +5% | 38Weak | 3 | $102M |
| CPMV Mosaic ImmunoEngineering Inc. | 0.3330 | - | - | 23No options | 1 | $2M |
| CRBP Corbus Pharmaceuticals Holdings, Inc. | 4.33 | 1.97 | -120% | 24Weak | 1 | $84M |
| CRBU Caribou Biosciences, Inc. | 0.4647 | - | - | 45Weak | 3 | $50M |
| CRDF Cardiff Oncology, Inc. | 0.9710 | 0.0302 | -3112% | 22Weak | 2 | $76M |
| CRIS Curis, Inc. | 0.5080 | - | - | 20No options | 0 | $991K |
| CRMD CorMedix Inc. | 7.46 | 83.15 | +91% | 69Good | 4 | $581M |
| CRSP CRISPR Therapeutics AG | 51.52 | - | - | 45Weak | 3 | $5.0B |
| CRVO CervoMed Inc. | 2.25 | 0.8036 | -180% | 15No options | 2 | $34M |
| CRVS Corvus Pharmaceuticals, Inc. | 9.85 | 0.0213 | -46156% | 34Weak | 2 | $829M |
| CSBR Champions Oncology, Inc. | 4.79 | 3.89 | -23% | 24Weak | 3 | $67M |
| CTMX CytomX Therapeutics, Inc. | 2.41 | - | - | 35Weak | 1 | $525M |
| CTNM Contineum Therapeutics, Inc. | 7.90 | 2.40 | -229% | 24Weak | 2 | $297M |
| CTXR Citius Pharmaceuticals, Inc. | 0.4600 | 0.9200 | +50% | 45Weak | 3 | $13M |
| CUBT Curative Biotechnology, Inc. | 0.9500 | - | - | 24No options | 2 | $6M |
| CUE Cue Biopharma, Inc. | 18.67 | - | - | 25Weak | 2 | $136M |
| CURX Curanex Pharmaceuticals Inc Common Stock | 4.83 | 3.26 | -48% | 13No options | 2 | $8M |
| CVKD Cadrenal Therapeutics, Inc. Common Stock | 0.9700 | 1.73 | +44% | 36No options | 2 | $3M |
| CVM CEL-SCI Corporation | 1.74 | 0.2128 | -718% | 12No options | 2 | $31M |
| CYDY CytoDyn Inc. | 0.2100 | - | - | 33No options | 3 | $309M |
| CYTK Cytokinetics, Incorporated | 63.92 | - | - | 45Weak | 1 | $8.9B |
| DARE Dare Bioscience, Inc. | 0.7400 | 0.1776 | -317% | 13No options | 2 | $11M |
| DBVT DBV Technologies S.A. | 9.11 | 1.73 | -428% | 22Weak | 2 | $218M |
| DCOY Decoy Therapeutics Inc. | 1.23 | 20.43 | +94% | 37No options | 2 | $654K |
| DFTX Definium Therapeutics, Inc. | 34.26 | 2.83 | -1109% | 42Weak | 3 | $4.6B |
| DMAC DiaMedica Therapeutics Inc. | 8.04 | 0.3042 | -2543% | 24Weak | 1 | $434M |
| DMRA Damora Therapeutics, Inc. | 18.74 | 189.26 | +90% | 39No options | 3 | $1.2B |
| DNA Ginkgo Bioworks Holdings, Inc. | 11.76 | - | - | 39Weak | 2 | $792M |
| DNLI Denali Therapeutics Inc. | 18.34 | 0.9548 | -1821% | 38Weak | 3 | $2.9B |
| DNTH Dianthus Therapeutics, Inc. | 74.53 | - | - | 45Weak | 1 | $4.2B |
| DRMA Dermata Therapeutics, Inc. | 0.9100 | 7.66 | +88% | 39No options | 1 | $4M |
| DRTS Alpha Tau Medical Ltd | 13.16 | - | - | 45Weak | 2 | $1.2B |
| DRUG Bright Minds Biosciences Inc. | 54.21 | 8.34 | -550% | 32Weak | 1 | $535M |
| DSGN Design Therapeutics, Inc. | 10.48 | 0.2574 | -3971% | 25Weak | 1 | $656M |
| DTIL Precision BioSciences, Inc. | 6.17 | - | - | 34Weak | 3 | $170M |
| DWTX Dogwood Therapeutics, Inc. | 1.25 | 0.6928 | -80% | 8No options | 1 | $42M |
| DYAI Dyadic International, Inc. | 0.4194 | - | - | 35Weak | 3 | $17M |
| DYN Dyne Therapeutics, Inc. | 15.29 | 6.74 | -127% | 41Weak | 2 | $2.9B |
| EDIT Editas Medicine, Inc. | 2.44 | - | - | 45Weak | 3 | $375M |
| EDSA Edesa Biotech, Inc. | 2.67 | 2.00 | -33% | 10No options | 1 | $26M |
| EIKN Eikon Therapeutics, Inc. Common Stock | 7.54 | - | - | 24No options | 0 | $408M |
| ELAB PMGC Holdings Inc. | 3.04 | 846.90 | +100% | 39No options | 3 | $2M |
| ELDN Eledon Pharmaceuticals, Inc. | 2.27 | 0.2360 | -862% | 25Weak | 1 | $184M |
| ELOX Eloxx Pharmaceuticals, Inc. | 13.70 | 1.23 | -1012% | 15No options | 3 | $47M |
| ELTX Elicio Therapeutics, Inc. | 1.78 | 0.2252 | -691% | 15Weak | 2 | $34M |
| ELUT Elutia Inc | 0.7888 | 24.46 | +97% | 39No options | 5 | $35M |
| ELVN Enliven Therapeutics, Inc. | 39.33 | 1.70 | -2210% | 44Weak | 2 | $2.9B |
| ENGN enGene Holdings Inc. | 1.71 | 0.2775 | -516% | 24Weak | 0 | $115M |
| ENLV Enlivex Therapeutics Ltd. | 0.2242 | 6,833.34 | +100% | 45Weak | 3 | $4M |
| ENSC Ensysce Biosciences, Inc. | 0.5979 | 0.0551 | -986% | 19No options | 3 | $12M |
| ENTA Enanta Pharmaceuticals, Inc. | 11.47 | - | - | 45Weak | 3 | $334M |
| ENTX Entera Bio Ltd. | 2.77 | 0.1387 | -1898% | 21Weak | 1 | $482M |
| ENVB Enveric Biosciences, Inc. | 1.39 | 12.40 | +89% | 37No options | 2 | $6M |
| EPRX Eupraxia Pharmaceuticals Inc. | 6.77 | 1.43 | -374% | 17No options | 2 | $227M |
| EQ Equillium, Inc. | 1.32 | 0.3155 | -318% | 15Weak | 1 | $84M |
| ERAS Erasca, Inc. | 14.87 | 0.0990 | -14917% | 32Weak | 1 | $5.2B |
| ERNA Ernexa Therapeutics Inc. | 2.17 | 1.87 | -16% | 14No options | 2 | $4M |
| ESLA Estrella Immunopharma, Inc. | 0.5352 | 0.0238 | -2148% | 21No options | 2 | $23M |
| EVAX Evaxion Biotech A/S | 2.80 | 31.73 | +91% | 39No options | 5 | $18M |
| EVGN Evogene Ltd. | 0.3999 | - | - | 24No options | 1 | $3M |
| EVMN Evommune, Inc. | 5.93 | - | - | 41Weak | 4 | $215M |
| EWTX Edgewise Therapeutics, Inc. | 38.20 | 0.5004 | -7534% | 36Weak | 1 | $4.1B |
| EXEL Exelixis, Inc. | 62.83 | 105.86 | +41% | 94Prime | 7 | $15.8B |
| EXOZ eXoZymes, Inc. | 4.00 | 0.1426 | -2706% | 5No options | 1 | $37M |
| EYPT EyePoint Pharmaceuticals, Inc. | 3.14 | - | - | 37Weak | 2 | $263M |
| FATE Fate Therapeutics, Inc. | 1.93 | - | - | 39Weak | 3 | $224M |
| FBIO Fortress Biotech, Inc. | 1.91 | 74.01 | +97% | 54Fair | 6 | $64M |
| FBIOP Fortress Biotech, Inc. | 16.89 | 457.36 | +96% | 39No options | 5 | $133M |
| FBLG FibroBiologics, Inc. Common Stock | 1.00 | 0.7260 | -38% | 14No options | 2 | $7M |
| FDMT 4D Molecular Therapeutics, Inc. | 12.87 | - | - | 45Weak | 3 | $711M |
| FENC Fennec Pharmaceuticals Inc. | 10.35 | - | - | 38Weak | 5 | $363M |
| FHTX Foghorn Therapeutics Inc. | 1.89 | - | - | 30Weak | 3 | $112M |
| FLNA Filana Therapeutics, Inc. | 0.7608 | 1.85 | +59% | 41Weak | 1 | $37M |
| FTH Faeth Therapeutics, Inc. | 20.60 | 5.16 | -299% | 16No options | 2 | $531M |
| FTRE Fortrea Holdings Inc. | 22.75 | 34.64 | +34% | 45Weak | 5 | $2.2B |
| FULC Fulcrum Therapeutics, Inc. | 3.67 | 3.01 | -22% | 30Weak | 2 | $280M |
| GALT Galectin Therapeutics Inc. | 3.71 | - | - | 29Weak | 2 | $244M |
| GANX Gain Therapeutics, Inc. | 1.33 | 0.6092 | -118% | 37Weak | 3 | $57M |
| GDTC CytoMed Therapeutics Limited | 0.8700 | - | - | 23No options | 2 | $10M |
| GENB Generate Biomedicines, Inc. | 13.06 | - | - | 45Weak | 0 | $1.7B |
| GERN Geron Corporation | 1.23 | - | - | 38Weak | 1 | $790M |
| GHRS GH Research PLC | 18.81 | 3.99 | -372% | 30Weak | 1 | $1.3B |
| GLSI Greenwich LifeSciences, Inc. | 15.32 | 0.1343 | -11309% | 9No options | 1 | $225M |
| GLUE Monte Rosa Therapeutics, Inc. | 10.12 | 33.55 | +70% | 45Weak | 2 | $863M |
| GMAB Genmab A/S | 37.82 | 44.48 | +15% | 73Good | 5 | $23.3B |
| GNLX Genelux Corporation | 2.48 | - | - | 35Weak | 2 | $112M |
| GNPX Genprex, Inc. | 2.29 | 168.15 | +99% | 39No options | 2 | $1M |
| GOSS Gossamer Bio, Inc. | 8.89 | 119.65 | +93% | 43Weak | 3 | $54M |
| GOVX GeoVax Labs, Inc. | 0.2578 | 0.3517 | +27% | 34No options | 2 | $3M |
| GPCR Structure Therapeutics Inc. | 22.19 | 13.18 | -68% | 30Weak | 1 | $1.3B |
| GRCE Grace Therapeutics, Inc. | 1.95 | 0.6964 | -180% | 23Weak | 2 | $32M |
| GRDX GridAI Technologies Corp. | 4.46 | - | - | 25No options | 2 | $32M |
| GRI GRI Bio, Inc. | 1.40 | 65.37 | +98% | 37No options | 1 | $3M |
| GTBP GT Biopharma, Inc. | 7.36 | 27.77 | +73% | 37No options | 1 | $9M |
| GUTS Fractyl Health, Inc. | 4.16 | 1.44 | -188% | 7No options | 2 | $55M |
| GWIN Glorywin Entertainment Group, Inc. | 0.6590 | - | - | 19No options | 0 | $235M |
| GYRE Gyre Therapeutics, Inc. | 6.40 | - | - | 34Weak | 1 | $679M |
| HALO Halozyme Therapeutics, Inc. | 121.51 | 84.14 | -44% | 62Fair | 6 | $13.8B |
| HCWB HCW Biologics Inc. | 1.23 | - | - | 22No options | 2 | $428K |
| HIND Vyome Holdings, Inc. | 1.91 | 1.68 | -14% | 22No options | 3 | $13M |
| HOWL Werewolf Therapeutics, Inc. | 0.9970 | 1.02 | +2% | 39Weak | 4 | $48M |
| HRGN Harvard Apparatus Regenerative Technology Inc. | 2.30 | 1.49 | -54% | 17No options | 4 | $40M |
| HRMY Harmony Biosciences Holdings, Inc. | 38.27 | 105.25 | +64% | 77Good | 5 | $2.2B |
| HRTX Heron Therapeutics, Inc. | 0.3765 | - | - | 36Weak | 2 | $71M |
| HSTC HST Global, Inc. | 0.7000 | 0.1233 | -468% | 17No options | 4 | $209M |
| HUMA Humacyte, Inc. | 0.4395 | - | - | 35Weak | 3 | $122M |
| HURA TuHURA Biosciences, Inc. | 1.83 | - | - | 22No options | 1 | $117M |
| HXBM Helix BioMedix, Inc. | 3.29 | - | - | 22No options | 0 | $739K |
| HYFT MindWalk Holdings Corp. | 1.40 | - | - | 34Weak | 3 | $66M |
| IBIO iBio, Inc. | 0.7828 | 0.4914 | -59% | 17No options | 2 | $50M |
| IBO Impact BioMedical Inc. | 3.15 | 1.37 | -130% | 13No options | 4 | $27M |
| IBRX ImmunityBio, Inc. | 10.00 | - | - | 45Weak | 3 | $10.6B |
| ICCC ImmuCell Corporation | 10.56 | 4.35 | -143% | 26No options | 7 | $96M |
| ICU SeaStar Medical Holding Corporation | 3.06 | 3.09 | +1% | 29No options | 2 | $9M |
| IDYA IDEAYA Biosciences, Inc. | 33.85 | - | - | 45Weak | 3 | $3.3B |
| IFRX InflaRx N.V. | 1.44 | 0.1964 | -633% | 19Weak | 3 | $212M |
| IGC IGC Pharma, Inc. | 0.2541 | - | - | 32Weak | 1 | $26M |
| IKT Inhibikase Therapeutics, Inc. | 1.83 | 1.41 | -30% | 16No options | 2 | $255M |
| IMA ImageneBio Inc | 4.03 | 4.48 | +10% | 25No options | 1 | $46M |
| IMCR Immunocore Holdings plc | 29.48 | - | - | 45Weak | 2 | $1.5B |
| IMMP Immutep Limited | 3.21 | - | - | 28Weak | 4 | $24M |
| IMMX Immix Biopharma, Inc. | 8.68 | 2.66 | -226% | 27Weak | 2 | $720M |
| IMNM Immunome, Inc. | 17.40 | 7.38 | -136% | 33Weak | 2 | $2.1B |
| IMNN Imunon, Inc. | 1.06 | 3.07 | +65% | 31No options | 1 | $6M |
| IMRN Immuron Limited | 1.03 | - | - | 30No options | 3 | $7M |
| IMRX Immuneering Corporation | 3.64 | 2.80 | -30% | 23Weak | 2 | $235M |
| IMTX Immatics N.V. | 7.14 | - | - | 45Weak | 1 | $1.1B |
| IMUX Immunic, Inc. | 7.10 | 0.6047 | -1074% | 18Weak | 2 | $97M |
| IMVT Immunovant, Inc. | 27.51 | 4.93 | -458% | 42Weak | 3 | $5.7B |
| INAB IN8bio, Inc. | 1.19 | 5.49 | +78% | 36No options | 2 | $12M |
| INBX Inhibrx Biosciences Inc. | 90.50 | 0.7387 | -12152% | 25Weak | 3 | $1.3B |
| INCY Incyte Corporation | 113.27 | 202.62 | +44% | 88Prime | 6 | $23.0B |
| INDP Indaptus Therapeutics, Inc. | 2.85 | 8.30 | +66% | 39No options | 2 | $323M |
| INKT MiNK Therapeutics, Inc. | 9.94 | 1.17 | -753% | 12No options | 2 | $51M |
| INMB INmune Bio, Inc. | 1.65 | 0.7650 | -116% | 21Weak | 1 | $46M |
| INO Inovio Pharmaceuticals, Inc. | 1.04 | 0.6920 | -50% | 20Weak | 0 | $72M |
| INSM Insmed Incorporated | 99.21 | - | - | 45Weak | 4 | $21.7B |
| INTS Intensity Therapeutics, Inc. | 3.38 | 8.35 | +60% | 31No options | 2 | $9M |
| INVA Innoviva, Inc. | 20.86 | 54.26 | +62% | 77Good | 4 | $1.5B |
| IONS Ionis Pharmaceuticals, Inc. | 44.12 | - | - | 45Weak | 2 | $7.3B |
| IOVA Iovance Biotherapeutics, Inc. | 14.72 | 3.82 | -286% | 39Weak | 4 | $6.7B |
| IPHA Innate Pharma S.A. | 1.48 | - | - | 27No options | 3 | $158M |
| IPSC Century Therapeutics, Inc. | 1.50 | 2.67 | +44% | 45Weak | 1 | $272M |
| IRD Opus Genetics, Inc. | 4.05 | - | - | 41Weak | 3 | $337M |
| IRLA IRulya Therapeutics Inc. | 33.23 | - | - | 25Weak | 3 | $34M |
| IRON Disc Medicine, Inc. | 56.65 | 2.31 | -2356% | 20Weak | 1 | $2.2B |
| ISCO International Stem Cell Corporation | 0.2700 | 1.32 | +80% | 39No options | 4 | $2M |
| IVA Inventiva S.A. | 3.11 | - | - | 34Weak | 3 | $162M |
| IVVD Invivyd, Inc. | 0.6688 | 10.25 | +93% | 45Weak | 1 | $197M |
| IXHL Incannex Healthcare Limited | 2.88 | 4.02 | +28% | 37Weak | 3 | $34M |
| JAGX Jaguar Health, Inc. | 4.59 | - | - | 32No options | 3 | $9M |
| JANX Janux Therapeutics, Inc. | 17.32 | - | - | 45Weak | 3 | $1.1B |
| JAZZ Jazz Pharmaceuticals plc | 214.42 | 253.97 | +16% | 80Prime | 8 | $13.9B |
| JBIO Jade Biosciences, Inc. | 13.76 | 2.74 | -403% | 32Weak | 2 | $875M |
| JSPR Jasper Therapeutics, Inc. | 0.5321 | 1.16 | +54% | 36Weak | 0 | $18M |
| JUNS Jupiter Neurosciences, Inc. | 3.14 | - | - | 26No options | 3 | $4M |
| KALA KALA BIO, Inc. | 0.1922 | 40.66 | +100% | 39No options | 3 | $4M |
| KAPA Kairos Pharma, Ltd. | 0.6706 | 1.64 | +59% | 39No options | 2 | $2M |
| KARD Kardigan, Inc. | 13.88 | 1.49 | -833% | 21Weak | 0 | $1.2B |
| KLRA Kailera Therapeutics, Inc. | 11.71 | 1.23 | -852% | 26Weak | 0 | $1.5B |
| KLRS Kalaris Therapeutics Inc | 2.19 | 6.25 | +65% | 33No options | 0 | $48M |
| KOD Kodiak Sciences Inc. | 88.12 | 0.7408 | -11795% | 32Weak | 1 | $5.5B |
| KPRX Kiora Pharmaceuticals, Inc. | 2.41 | 2.55 | +5% | 27No options | 2 | $11M |
| KPTI Karyopharm Therapeutics Inc. | 0.3508 | - | - | 37Weak | 2 | $8M |
| KROS Keros Therapeutics, Inc. | 11.10 | - | - | 42Weak | 3 | $220M |
| KRRO Korro Bio, Inc. | 9.31 | 10.44 | +11% | 40Weak | 2 | $137M |
| KRSA Korsana Biosciences, Inc. | 33.65 | 6.74 | -399% | 13No options | 1 | $158M |
| KRYS Krystal Biotech, Inc. | 330.00 | 294.13 | -12% | 61Fair | 5 | $9.8B |
| KTTA Pasithea Therapeutics Corp. | 0.4101 | 7.85 | +95% | 37No options | 2 | $14M |
| KURA Kura Oncology, Inc. | 9.70 | 16.14 | +40% | 45Weak | 3 | $863M |
| KYMR Kymera Therapeutics, Inc. | 108.14 | 0.2471 | -43656% | 40Weak | 4 | $8.9B |
| KYNB Kyntra Bio, Inc. | 5.36 | 873.47 | +99% | 47Weak | 5 | $22M |
| KYTX Kyverna Therapeutics, Inc. | 5.97 | 2.04 | -192% | 16Weak | 1 | $369M |
| KZIA Kazia Therapeutics Ltd ADR | 7.40 | - | - | 33Weak | 3 | $12M |
| LABT Lakewood-Amedex Biotherapeutics, Inc. | 0.6124 | - | - | 20No options | 0 | $1M |
| LBRX LB Pharmaceuticals Inc Common Stock | 36.69 | 9.67 | -279% | 38Weak | 2 | $1.2B |
| LCTX Lineage Cell Therapeutics, Inc. | 0.9903 | - | - | 39Weak | 3 | $250M |
| LEGN Legend Biotech Corporation | 19.80 | - | - | 45Weak | 3 | $3.7B |
| LENZ LENZ Therapeutics, Inc. | 3.57 | 2.36 | -51% | 22Weak | 2 | $112M |
| LEXX Lexaria Bioscience Corp. | 2.99 | - | - | 27No options | 2 | $5M |
| LGND Ligand Pharmaceuticals Incorporated | 298.50 | 207.62 | -44% | 48Weak | 5 | $6.0B |
| LGVN Longeveron Inc. | 1.50 | - | - | 27No options | 2 | $5M |
| LIMN Liminatus Pharma, Inc. Class A Common Stock | 3.21 | - | - | 27No options | 2 | $4M |
| LITS Lite Strategy, Inc. | 1.20 | 0.1580 | -656% | 18Weak | 1 | $36M |
| LKFT Lakefront Biotherapeutics N.V. | 29.93 | 237.87 | +87% | 79Good | 5 | $2.0B |
| LNAI Lunai Bioworks Inc. | 0.8255 | 108.83 | +99% | 38Weak | 3 | $4M |
| LONA LeonaBio, Inc. | 5.29 | 15.08 | +65% | 31No options | 1 | $21M |
| LPCN Lipocine Inc. | 1.68 | 0.6721 | -150% | 15No options | 2 | $14M |
| LRMR Larimar Therapeutics, Inc. | 1.99 | 1.06 | -88% | 24Weak | 1 | $207M |
| LSTA Lisata Therapeutics, Inc. | 1.07 | 1.91 | +44% | 35No options | 1 | $10M |
| LTRN Lantern Pharma Inc. | 0.6668 | - | - | 27Weak | 1 | $9M |
| LXEO Lexeo Therapeutics, Inc. Common Stock | 2.76 | 0.9467 | -192% | 28Weak | 1 | $227M |
| LXRX Lexicon Pharmaceuticals, Inc. | 1.65 | - | - | 43Weak | 2 | $734M |
| LYEL Lyell Immunopharma, Inc. | 8.19 | 0.3586 | -2184% | 18Weak | 1 | $201M |
| LYRA Lyra Therapeutics, Inc. | 0.1900 | - | - | 28No options | 3 | $337K |
| MAIA MAIA Biotechnology, Inc. | 1.12 | 269.53 | +100% | 39No options | 2 | $69M |
| MANE Veradermics, Incorporated | 115.07 | 0.5980 | -19143% | 37Weak | 3 | $4.8B |
| MAZE Maze Therapeutics, Inc. | 27.48 | 3.82 | -618% | 35Weak | 3 | $1.5B |
| MBAI MBody AI Ltd. | 3.10 | 35.80 | +91% | 37No options | 0 | $3M |
| MBIO Mustang Bio, Inc. | 0.3861 | 2.93 | +87% | 33No options | 1 | $3M |
| MBRX Moleculin Biotech, Inc. | 0.3701 | 4.51 | +92% | 36No options | 1 | $2M |
| MBX MBX Biosciences, Inc. Common Stock | 50.71 | 2.02 | -2406% | 28Weak | 1 | $2.4B |
| MCRB Seres Therapeutics, Inc. | 2.53 | - | - | 33Weak | 3 | $25M |
| MDCX Medicus Pharma Ltd. Common Stock | 3.43 | 4.17 | +18% | 33No options | 2 | $5M |
| MDGL Madrigal Pharmaceuticals, Inc. | 459.81 | 2,351.92 | +80% | 45Weak | 2 | $10.6B |
| MDWD MediWound Ltd. | 12.21 | - | - | 43Weak | 1 | $158M |
| MDXG MiMedx Group, Inc. | 4.68 | 2.75 | -70% | 53Fair | 6 | $682M |
| MENS Jyong Biotech Ltd. Ordinary Shares | 1.98 | - | - | 30Weak | 3 | $151M |
| MESO Mesoblast Limited | 13.95 | - | - | 45Weak | 4 | $1.8B |
| MGNX MacroGenics, Inc. | 3.37 | - | - | 32Weak | 1 | $215M |
| MGTX MeiraGTx Holdings plc | 9.89 | 20.77 | +52% | 59Fair | 6 | $950M |
| MGX Metagenomi, Inc. Common Stock | 0.8452 | - | - | 30No options | 2 | $32M |
| MIRM Mirum Pharmaceuticals, Inc. | 82.39 | - | - | 45Weak | 3 | $5.3B |
| MIST Milestone Pharmaceuticals Inc. | 0.7945 | 0.1538 | -417% | 27Weak | 4 | $99M |
| MLEC Moolec Science S.A. | 1.87 | 8,260.03 | +100% | 39No options | 1 | $1M |
| MLTX MoonLake Immunotherapeutics | 10.26 | 4.08 | -151% | 31Weak | 1 | $873M |
| MLYS Mineralys Therapeutics, Inc. | 21.64 | 2.53 | -756% | 40Weak | 2 | $1.9B |
| MNKD MannKind Corporation | 3.19 | - | - | 45Weak | 1 | $1.0B |
| MNOV MediciNova, Inc. | 1.45 | 0.6142 | -136% | 17Weak | 2 | $71M |
| MNPR Monopar Therapeutics Inc. | 71.80 | 7.99 | -798% | 11No options | 0 | $482M |
| MOLN Molecular Partners AG | 3.75 | 2.59 | -45% | 10No options | 1 | $143M |
| MPLT MapLight Therapeutics, Inc. | 8.02 | 0.9297 | -763% | 21Weak | 2 | $342M |
| MREO Mereo BioPharma Group plc | 0.3091 | 0.2632 | -17% | 26Weak | 1 | $49M |
| MRKR Marker Therapeutics, Inc. | 0.9200 | 1.08 | +15% | 30No options | 2 | $15M |
| MRNA Moderna, Inc. | 236.50 | - | - | 45Weak | 2 | $94.4B |
| MRVI Maravai LifeSciences Holdings, Inc. | 7.07 | 2.40 | -195% | 31Weak | 4 | $2.0B |
| MSLE Satellos Bioscience Inc. | 6.84 | 4.93 | -39% | 13No options | 1 | $9M |
| MTNB Matinas BioPharma Holdings, Inc. | 2.42 | 6.45 | +62% | 33No options | 1 | $1M |
| MTVA MetaVia Inc. | 1.37 | 5.15 | +73% | 33No options | 0 | $9M |
| MXCT MaxCyte, Inc. | 1.30 | - | - | 38Weak | 2 | $134M |
| NAGE Niagen Bioscience Inc | 2.58 | 5.41 | +52% | 56Fair | 4 | $204M |
| NAMS NewAmsterdam Pharma Company N.V. | 20.62 | 3.67 | -462% | 37Weak | 1 | $2.4B |
| NAUT Nautilus Biotechnolgy, Inc. | 2.16 | - | - | 40Weak | 3 | $275M |
| NBIX Neurocrine Biosciences, Inc. | 136.95 | 236.51 | +42% | 87Prime | 5 | $13.9B |
| NBP NovaBridge Biosciences | 1.29 | 0.1073 | -1102% | 18Weak | 1 | $149M |
| NBTX Nanobiotix S.A. | 22.23 | - | - | 40Weak | 2 | $1.1B |
| NCEL NewcelX Ltd. | 2.85 | 4.47 | +36% | 35No options | 1 | $1M |
| NCNA NuCana plc | 1.02 | 14.66 | +93% | 33No options | 2 | $6M |
| NDTP NDT Pharmaceuticals Inc. | 0.3210 | 0.0000 | -2863694% | 15No options | 3 | $51M |
| NERV Minerva Neurosciences, Inc. | 2.42 | 1.98 | -22% | 18Weak | 1 | $116M |
| NEUP Neuphoria Therapeutics Inc. | 3.31 | 3,129.10 | +100% | 38No options | 1 | $18M |
| NGEN NervGen Pharma Corp. Common stock | 1.62 | 0.1734 | -834% | 23Weak | 2 | $174M |
| NGNE Neurogene Inc. | 23.95 | 4.36 | -450% | 22Weak | 1 | $378M |
| NIKI Niki BioSolutions, Inc. | 2.22 | 0.1355 | -1538% | 10No options | 1 | $181K |
| NKTR Nektar Therapeutics | 37.72 | - | - | 45Weak | 1 | $1.1B |
| NKTX Nkarta, Inc. | 1.93 | - | - | 34Weak | 1 | $138M |
| NMAD NOMAD Power Solutions, Inc. | 4.09 | 0.8270 | -395% | 14Weak | 0 | $51M |
| NMRA Neumora Therapeutics, Inc. Common Stock | 0.4270 | 1.10 | +61% | 43Weak | 2 | $80M |
| NNVC NanoViricides, Inc. | 1.37 | 1,583,177.91 | +100% | 45Weak | 3 | $35M |
| NRIX Nurix Therapeutics, Inc. | 24.95 | 36.95 | +32% | 74Good | 7 | $2.6B |
| NRSN NeuroSense Therapeutics Ltd. | 3.17 | - | - | 21No options | 1 | $6M |
| NRXP NRx Pharmaceuticals, Inc. | 2.71 | 0.6997 | -287% | 26Weak | 4 | $117M |
| NRXS NeurAxis, Inc. | 7.74 | - | - | 45Weak | 3 | $97M |
| NTHI Neonc Technologies Holdings, Inc. | 2.75 | - | - | 27No options | 2 | $79M |
| NTLA Intellia Therapeutics, Inc. | 11.34 | - | - | 45Weak | 4 | $1.6B |
| NTRB Nutriband Inc. | 6.27 | - | - | 24No options | 3 | $76M |
| NUVB Nuvation Bio Inc. | 4.75 | 3.07 | -55% | 38Weak | 3 | $1.7B |
| NVAX Novavax, Inc. | 12.82 | - | - | 44Weak | 1 | $2.1B |
| NVCT Nuvectis Pharma, Inc. | 18.93 | 1.18 | -1506% | 24Weak | 1 | $618M |
| NWBO Northwest Biotherapeutics, Inc. | 0.1500 | - | - | 30No options | 1 | $256M |
| NXTC NextCure, Inc. | 6.88 | 6.72 | -2% | 19No options | 1 | $31M |
| OABI OmniAb, Inc. | 4.73 | - | - | 43Weak | 4 | $688M |
| OBIO Orchestra BioMed Holdings, Inc. | 5.74 | - | - | 36Weak | 3 | $345M |
| OCGN Ocugen, Inc. | 0.8137 | - | - | 35Weak | 2 | $276M |
| OCS Oculis Holding AG | 7.40 | 1.81 | -309% | 38Weak | 4 | $456M |
| OCUL Ocular Therapeutix, Inc. | 7.38 | - | - | 42Weak | 2 | $1.6B |
| ODTX Odyssey Therapeutics, Inc. | 17.57 | - | - | 24No options | 0 | $844M |
| OGEN Oragenics, Inc. | 0.4360 | 1.54 | +72% | 36No options | 1 | $2M |
| OKUR OnKure Therapeutics, Inc. | 2.13 | 4.23 | +50% | 45Weak | 2 | $86M |
| OKYO OKYO Pharma Limited | 1.43 | 0.2145 | -567% | 13No options | 2 | $75M |
| OLMA Olema Pharmaceuticals, Inc. | 6.87 | 0.4892 | -1304% | 24Weak | 2 | $601M |
| OMER Omeros Corporation | 18.79 | 66.86 | +72% | 64Fair | 6 | $1.4B |
| ONC BeOne Medicines AG | 374.08 | 200.58 | -86% | 54Fair | 6 | $40.0B |
| ONCO Onconetix, Inc. | 0.5480 | 1.38 | +60% | 31No options | 1 | $2M |
| ONCY Oncolytics Biotech Inc. | 0.5476 | 0.0200 | -2639% | 17No options | 1 | $55M |
| ORIC ORIC Pharmaceuticals, Inc. | 12.77 | 0.3488 | -3561% | 25Weak | 1 | $1.3B |
| ORKA Oruka Therapeutics, Inc. | 73.87 | 0.9005 | -8103% | 37Weak | 2 | $4.9B |
| ORMP Oramed Pharmaceuticals Inc. | 4.18 | 83.31 | +95% | 45Weak | 3 | $174M |
| OSTX OS Therapies Incorporated | 1.41 | - | - | 26No options | 1 | $66M |
| OTLK Outlook Therapeutics, Inc. | 0.5000 | 0.7306 | +32% | 45Weak | 4 | $122M |
| OVID Ovid Therapeutics Inc. | 2.26 | - | - | 40Weak | 1 | $441M |
| PALI Palisade Bio, Inc. | 1.48 | 2.39 | +38% | 39No options | 4 | $258M |
| PASG Passage Bio, Inc. | 3.66 | 6.70 | +45% | 33No options | 1 | $12M |
| PBLS Parabilis Medicines, Inc. | 25.89 | - | - | 39Weak | 0 | $3.2B |
| PBM Psyence Biomedical Ltd. | 4.13 | 9.63 | +57% | 39No options | 3 | $79K |
| PBYI Puma Biotechnology, Inc. | 10.20 | 14.98 | +32% | 72Good | 7 | $527M |
| PCSA Processa Pharmaceuticals, Inc. | 1.62 | 3.49 | +54% | 35No options | 1 | $4M |
| PCVX Vaxcyte, Inc. | 67.55 | - | - | 45Weak | 0 | $10.4B |
| PDSB PDS Biotechnology Corporation | 1.41 | 0.1443 | -877% | 23Weak | 2 | $79M |
| PEPG PepGen Inc. | 2.32 | 1.01 | -129% | 19Weak | 2 | $160M |
| PGEN Precigen, Inc. | 7.36 | - | - | 45Weak | 4 | $2.6B |
| PHAR Pharming Group N.V. | 9.64 | 6.44 | -50% | 27No options | 5 | $682M |
| PHAT Phathom Pharmaceuticals, Inc. | 7.40 | - | - | 41Weak | 3 | $599M |
| PHIO Phio Pharmaceuticals Corp. | 0.9496 | 3.45 | +72% | 38No options | 2 | $11M |
| PHVS Pharvaris N.V. | 30.02 | 5.50 | -445% | 37Weak | 2 | $2.1B |
| PLRX Pliant Therapeutics, Inc. | 0.8839 | 0.2713 | -226% | 23Weak | 2 | $55M |
| PLRZ Polyrizon Ltd. | 10.41 | 0.8121 | -1182% | 9No options | 0 | $12M |
| PLUR Pluri Inc. | 0.9300 | - | - | 26No options | 2 | $10M |
| PLX Protalix BioTherapeutics, Inc. | 2.61 | 2.24 | -17% | 35Weak | 4 | $210M |
| PLYX Polaryx Therapeutics, Inc. Common Stock | 1.97 | 0.0993 | -1885% | 17No options | 3 | $98M |
| PMCB PharmaCyte Biotech, Inc. | 0.3485 | 2.22 | +84% | 38Weak | 2 | $4M |
| PMN ProMIS Neurosciences, Inc. | 8.29 | 1.50 | -452% | 12No options | 2 | $74M |
| PMVP PMV Pharmaceuticals, Inc. | 1.24 | 0.6530 | -90% | 18Weak | 1 | $66M |
| PPBT Purple Biotech Ltd. | 1.23 | 1.39 | +12% | 34Weak | 2 | $170K |
| PPCB Propanc Biopharma, Inc. | 0.3657 | 0.2233 | -64% | 13No options | 3 | $833K |
| PRAX Praxis Precision Medicines, Inc. | 239.02 | 14.95 | -1499% | 32Weak | 2 | $6.7B |
| PRLD Prelude Therapeutics Incorporated | 3.23 | 3.61 | +11% | 44Weak | 4 | $187M |
| PRME Prime Medicine, Inc. | 3.13 | - | - | 35Weak | 2 | $568M |
| PROK ProKidney Corp. | 1.47 | 0.8634 | -70% | 25Weak | 1 | $494M |
| PRQR ProQR Therapeutics N.V. | 1.47 | - | - | 35Weak | 1 | $203M |
| PRTA Prothena Corporation plc | 8.37 | 3.74 | -124% | 38Weak | 3 | $430M |
| PTCT PTC Therapeutics, Inc. | 59.67 | - | - | 45Weak | 2 | $5.0B |
| PTGX Protagonist Therapeutics, Inc. | 136.28 | 38.39 | -255% | 51Fair | 6 | $8.8B |
| PTHS Pelthos Therapeutics Inc. | 20.25 | 92.90 | +78% | 36No options | 4 | $78M |
| PTIX Protagenic Therapeutics, Inc. | 0.8000 | 26.61 | +97% | 39No options | 5 | $1M |
| PTN Palatin Technologies, Inc. | 7.42 | - | - | 32No options | 4 | $13M |
| PULM Pulmatrix, Inc. | 1.37 | 1.05 | -30% | 8No options | 1 | $5M |
| PVLA Palvella Therapeutics, Inc. | 122.58 | 4.71 | -2501% | 40Weak | 3 | $1.8B |
| PYPD PolyPid Ltd. | 4.83 | 0.1249 | -3766% | 18Weak | 1 | $98M |
| PYXS Pyxis Oncology, Inc. | 1.79 | 1.63 | -10% | 33Weak | 2 | $113M |
| QNRX Quoin Pharmaceuticals, Ltd. | 4.10 | 2,547.50 | +100% | 35No options | 1 | $8M |
| QNTM Quantum BioPharma Ltd. | 2.66 | 0.0860 | -2991% | 13No options | 2 | $17M |
| QTTB Q32 Bio Inc. | 8.01 | 66.58 | +88% | 69Good | 5 | $238M |
| QURE uniQure N.V. | 20.97 | - | - | 45Weak | 3 | $1.5B |
| RADX Radiopharm Theranostics Limited | 1.12 | - | - | 21No options | 0 | $1M |
| RANI Rani Therapeutics Holdings, Inc. | 0.6702 | 0.3260 | -106% | 30Weak | 5 | $44M |
| RAPP Rapport Therapeutics, Inc. Common Stock | 28.33 | 0.7949 | -3464% | 23Weak | 2 | $1.4B |
| RARE Ultragenyx Pharmaceutical Inc. | 14.90 | - | - | 45Weak | 2 | $1.5B |
| RCKT Rocket Pharmaceuticals, Inc. | 2.21 | 0.4741 | -366% | 26Weak | 1 | $243M |
| RCUS Arcus Biosciences, Inc. | 22.53 | - | - | 39Weak | 0 | $2.8B |
| REGN Regeneron Pharmaceuticals, Inc. | 778.36 | 672.97 | -16% | 68Good | 7 | $80.1B |
| REPL Replimune Group, Inc. | 11.39 | 1.00 | -1039% | 29Weak | 1 | $1.1B |
| REVB Revelation Biosciences, Inc. | 0.7197 | 15.15 | +95% | 38No options | 2 | $3M |
| RGNX REGENXBIO Inc. | 6.88 | - | - | 38Weak | 2 | $454M |
| RIGL Rigel Pharmaceuticals, Inc. | 46.82 | 408.96 | +89% | 64Fair | 4 | $875M |
| RLAY Relay Therapeutics, Inc. | 17.06 | - | - | 45Weak | 3 | $3.7B |
| RLMD Relmada Therapeutics, Inc. | 3.24 | 0.0515 | -6194% | 29Weak | 2 | $346M |
| RLYB Rallybio Corporation | 16.91 | 120.56 | +86% | 39No options | 5 | $90M |
| RNA Atrium Therapeutics, Inc. | 7.68 | - | - | 30Weak | 0 | $131M |
| RNAC Cartesian Therapeutics, Inc. | 6.34 | 4.00 | -59% | 20Weak | 2 | $192M |
| RNAZ TransCode Therapeutics, Inc. | 1.73 | 26.00 | +93% | 33No options | 0 | $2M |
| RNTX Rein Therapeutics Inc. | 0.5860 | - | - | 31No options | 2 | $16M |
| RNXT RenovoRx, Inc. | 1.12 | 0.8497 | -32% | 19No options | 3 | $51M |
| ROIV Roivant Sciences Ltd. | 33.62 | 2.89 | -1063% | 44Weak | 0 | $24.3B |
| RVMD Revolution Medicines, Inc. | 193.52 | 0.8792 | -21911% | 42Weak | 1 | $41.5B |
| RVPH Reviva Pharmaceuticals Holdings, Inc. | 0.4782 | 3.09 | +85% | 36Weak | 1 | $6M |
| RXRX Recursion Pharmaceuticals, Inc. | 3.74 | - | - | 45Weak | 3 | $2.0B |
| RYTM Rhythm Pharmaceuticals, Inc. | 86.71 | - | - | 45Weak | 3 | $6.0B |
| RZLT Rezolute, Inc. | 4.23 | 0.0528 | -7912% | 24Weak | 1 | $407M |
| SABS SAB Biotherapeutics, Inc. | 2.49 | 0.0409 | -5987% | 20Weak | 1 | $227M |
| SANA Sana Biotechnology, Inc. | 2.33 | - | - | 42Weak | 1 | $698M |
| SCNI Scinai Immunotherapeutics Ltd. | 0.8800 | 98.61 | +99% | 39No options | 2 | $455K |
| SEER Seer, Inc. | 2.08 | - | - | 33Weak | 3 | $115M |
| SEPN Septerna Inc | 36.32 | 46.79 | +22% | 45Weak | 3 | $1.7B |
| SER Serina Therapeutics, Inc. | 1.71 | 0.1037 | -1549% | 10No options | 2 | $26M |
| SGMT Sagimet Biosciences Inc. | 7.55 | 1.05 | -621% | 29Weak | 2 | $246M |
| SGP SpyGlass Pharma, Inc. Common Stock | 23.69 | 2.90 | -716% | 8No options | 0 | $792M |
| SILO Silo Pharma, Inc. | 1.20 | 6.63 | +82% | 35No options | 1 | $1M |
| SION Sionna Therapeutics, Inc. | 4.09 | 1.23 | -233% | 21Weak | 0 | $185M |
| SKYE Skye Bioscience, Inc. | 1.57 | 0.7856 | -100% | 3Weak | 1 | $7M |
| SLBT SL Science Holding Ltd | 1.55 | - | - | 25No options | 0 | $869M |
| SLDB Solid Biosciences Inc. | 5.47 | 0.4110 | -1230% | 22Weak | 2 | $586M |
| SLGL Sol-Gel Technologies Ltd. | 69.50 | 1.77 | -3835% | 16No options | 2 | $228M |
| SLN Silence Therapeutics plc | 8.98 | 1.81 | -397% | 36Weak | 1 | $424M |
| SLS SELLAS Life Sciences Group, Inc. | 11.88 | 0.6270 | -1795% | 25Weak | 2 | $2.4B |
| SLXN Silexion Therapeutics Ltd. | 0.1710 | 35.90 | +100% | 39No options | 2 | $72K |
| SMMT Summit Therapeutics Inc. | 15.13 | 0.2422 | -6147% | 32Weak | 2 | $12.1B |
| SNDX Syndax Pharmaceuticals, Inc. | 13.53 | 12.49 | -8% | 45Weak | 3 | $1.2B |
| SNGX Soligenix, Inc. | 0.3407 | 1.27 | +73% | 35No options | 2 | $7M |
| SNTI Senti Biosciences, Inc. | 0.2408 | - | - | 23No options | 2 | $7M |
| SPRB Spruce Biosciences, Inc. | 38.98 | 61.81 | +37% | 31No options | 2 | $112M |
| SPRC SciSparc Ltd. | 3.63 | - | - | 21No options | 2 | $2M |
| SPRO Spero Therapeutics, Inc. | 1.12 | 3.81 | +71% | 56Fair | 6 | $65M |
| SPRY ARS Pharmaceuticals, Inc. | 3.93 | - | - | 37Weak | 2 | $391M |
| SPTX Seaport Therapeutics, Inc. Common Stock | 16.68 | 1.08 | -1439% | 10No options | 0 | $893M |
| SRPT Sarepta Therapeutics, Inc. | 16.83 | - | - | 45Weak | 3 | $1.8B |
| SRRK Scholar Rock Holding Corporation | 39.60 | 1.79 | -2115% | 41Weak | 2 | $4.8B |
| SRZN Surrozen, Inc. | 23.75 | 11.33 | -110% | 25Weak | 1 | $178M |
| STOK Stoke Therapeutics, Inc. | 23.26 | - | - | 45Weak | 2 | $1.5B |
| STRO Sutro Biopharma, Inc. | 10.52 | - | - | 39Weak | 3 | $174M |
| STTK Shattuck Labs, Inc. | 5.33 | 0.6164 | -765% | 30Weak | 2 | $535M |
| SVRA Savara Inc. | 4.76 | - | - | 36Weak | 1 | $978M |
| SXTP 60 Degrees Pharmaceuticals, Inc. | 0.8802 | - | - | 20No options | 2 | $3M |
| SYBX Synlogic, Inc. | 1.02 | 1.18 | +14% | 28No options | 1 | $12M |
| SYRE Spyre Therapeutics, Inc. | 78.63 | 1.22 | -6334% | 36Weak | 2 | $7.3B |
| TARA Protara Therapeutics, Inc. | 2.48 | 1.03 | -140% | 20Weak | 1 | $147M |
| TARS Tarsus Pharmaceuticals, Inc. | 72.29 | 31.76 | -128% | 42Weak | 3 | $3.4B |
| TCRT Alaunos Therapeutics, Inc. | 2.07 | 0.3360 | -516% | 18No options | 1 | $5M |
| TCRX TScan Therapeutics, Inc. | 0.2106 | - | - | 31No options | 3 | $13M |
| TECH Bio-Techne Corporation | 72.50 | 19.15 | -279% | 62Fair | 8 | $11.4B |
| TECX Tectonic Therapeutic, Inc. | 20.96 | 13.73 | -53% | 22Weak | 1 | $410M |
| TELO Telomir Pharmaceuticals, Inc. Common Stock | 1.05 | 0.1992 | -427% | 13No options | 2 | $77M |
| TENX Tenax Therapeutics, Inc. | 1.54 | 2.35 | +35% | 45Weak | 1 | $41M |
| TGTX TG Therapeutics, Inc. | 54.37 | 83.89 | +35% | 78Good | 5 | $8.3B |
| TIL Instil Bio, Inc. | 5.95 | - | - | 23No options | 3 | $40M |
| TLSA Tiziana Life Sciences Ltd | 1.05 | 0.0186 | -5553% | 20Weak | 1 | $67M |
| TLX Telix Pharmaceuticals Limited | 10.65 | 3.55 | -200% | 25No options | 4 | $3.6B |
| TNGX Tango Therapeutics, Inc. | 22.19 | - | - | 43Weak | 2 | $3.7B |
| TNXP Tonix Pharmaceuticals Holding Corp. | 6.40 | 24.35 | +74% | 45Weak | 3 | $110M |
| TNYA Tenaya Therapeutics, Inc. | 0.3905 | 0.5664 | +31% | 45Weak | 3 | $88M |
| TOVX Theriva Biologics, Inc. | 0.2099 | 1.07 | +80% | 39No options | 2 | $10M |
| TPST Tempest Therapeutics, Inc. | 0.6352 | - | - | 23No options | 1 | $11M |
| TRAW Traws Pharma, Inc. | 0.4012 | - | - | 28No options | 2 | $6M |
| TRAX First Tracks Biotherapeutics Inc | 34.13 | 6.37 | -435% | 24Weak | 0 | $1.2B |
| TRDA Entrada Therapeutics, Inc. | 4.55 | 8.84 | +49% | 45Weak | 1 | $177M |
| TRVI Trevi Therapeutics, Inc. | 12.06 | 0.1068 | -11195% | 39Weak | 1 | $1.7B |
| TSHA Taysha Gene Therapies, Inc. | 3.51 | 0.5789 | -506% | 30Weak | 2 | $1.1B |
| TTRX Turn Therapeutics Inc. | 11.11 | 0.1777 | -6154% | 15Weak | 1 | $331M |
| TVGN Tevogen Bio Holdings Inc. | 6.51 | - | - | 27No options | 3 | $27M |
| TVRD Tvardi Therapeutics, Inc. | 1.00 | 2.25 | +56% | 40Weak | 1 | $13M |
| TVTX Travere Therapeutics, Inc. | 53.27 | 13.88 | -284% | 45Weak | 5 | $5.0B |
| TWST Twist Bioscience Corporation | 148.16 | - | - | 45Weak | 2 | $9.8B |
| TXG 10x Genomics, Inc. | 73.10 | 19.50 | -275% | 38Weak | 3 | $9.5B |
| TYRA Tyra Biosciences, Inc. | 18.70 | 1.18 | -1481% | 32Weak | 1 | $1.1B |
| UNCY Unicycive Therapeutics, Inc. | 3.70 | 1.81 | -105% | 21Weak | 2 | $101M |
| UPB Upstream Bio, Inc. | 3.42 | - | - | 37Weak | 2 | $187M |
| URGN UroGen Pharma Ltd. | 36.58 | - | - | 45Weak | 2 | $1.8B |
| UTHR United Therapeutics Corporation | 540.03 | 872.54 | +38% | 87Prime | 6 | $23.2B |
| VALN Valneva SE | 5.66 | - | - | 23No options | 1 | $537M |
| VANI Vivani Medical, Inc. | 1.16 | - | - | 23Weak | 2 | $105M |
| VBIO Valion Bio, Inc. | 1.45 | 5.14 | +72% | 36No options | 2 | $6M |
| VCEL Vericel Corporation | 40.25 | 20.44 | -97% | 54Fair | 6 | $2.1B |
| VCNX Vaccinex, Inc. | 1.00 | - | - | 30No options | 4 | $3M |
| VCRE Vicore Pharma Holding AB | 9.08 | 2.35 | -287% | 10No options | 0 | $256M |
| VERA Vera Therapeutics, Inc. | 26.74 | 4.05 | -560% | 37Weak | 1 | $1.9B |
| VERU Veru Inc. | 2.13 | 0.6643 | -221% | 18Weak | 1 | $36M |
| VICP Vicapsys Life Sciences, Inc. | 0.4000 | - | - | 27No options | 3 | $13M |
| VIR Vir Biotechnology, Inc. | 10.41 | - | - | 45Weak | 3 | $1.8B |
| VIVS VivoSim Labs, Inc. | 0.1609 | 1.68 | +90% | 38No options | 1 | $3M |
| VKTX Viking Therapeutics, Inc. | 25.47 | 1.03 | -2365% | 40Weak | 1 | $3.2B |
| VNDA Vanda Pharmaceuticals Inc. | 4.22 | - | - | 43Weak | 3 | $255M |
| VOR Vor Biopharma Inc. | 18.75 | 86.89 | +78% | 45Weak | 3 | $1.0B |
| VRAX Virax Biolabs Group Limited | 1.65 | 14.57 | +89% | 38No options | 2 | $2M |
| VRCA Verrica Pharmaceuticals Inc. | 3.83 | - | - | 40Weak | 4 | $66M |
| VRDN Viridian Therapeutics, Inc. | 18.38 | - | - | 45Weak | 3 | $2.1B |
| VRTX Vertex Pharmaceuticals Incorporated | 498.50 | 315.11 | -58% | 61Fair | 5 | $126.4B |
| VSTM Verastem, Inc. | 7.71 | - | - | 45Weak | 4 | $698M |
| VTGN VistaGen Therapeutics, Inc. | 0.2066 | 0.6929 | +70% | 45Weak | 3 | $9M |
| VTVT vTv Therapeutics Inc. | 27.52 | 10.43 | -164% | 13No options | 2 | $109M |
| VXRT Vaxart, Inc. | 0.4600 | 4.86 | +91% | 39No options | 5 | $112M |
| VYGR Voyager Therapeutics, Inc. | 2.01 | - | - | 36Weak | 2 | $124M |
| WHWK Whitehawk Therapeutics Inc | 2.97 | - | - | 39Weak | 1 | $169M |
| WVE Wave Life Sciences Ltd. | 3.09 | 1.35 | -128% | 30Weak | 3 | $609M |
| XBIO Xenetic Biosciences, Inc. | 2.10 | - | - | 27No options | 3 | $5M |
| XBIT XBiotech Inc. | 2.16 | 4.08 | +47% | 36Weak | 1 | $66M |
| XCUR Exicure, Inc. | 1.21 | 0.3541 | -242% | 4No options | 1 | $8M |
| XENE Xenon Pharmaceuticals Inc. | 33.90 | 2.44 | -1290% | 45Weak | 2 | $3.3B |
| XERS Xeris Biopharma Holdings, Inc. | 9.77 | 6.45 | -51% | 41Weak | 5 | $1.8B |
| XFOR X4 Pharmaceuticals, Inc. | 2.45 | 18.79 | +87% | 45Weak | 3 | $243M |
| XLO Xilio Therapeutics, Inc. | 8.90 | 298.80 | +97% | 39No options | 3 | $59M |
| XNCR Xencor, Inc. | 23.39 | - | - | 39Weak | 2 | $1.7B |
| XRTX XORTX Therapeutics Inc. | 1.56 | 0.3915 | -298% | 10No options | 1 | $3M |
| XTLB XTL Biopharmaceuticals Ltd. | 1.88 | - | - | 25No options | 2 | $2M |
| YARW Yarrow Bioscience Inc | 18.90 | 159.75 | +88% | 38No options | 3 | $176M |
| YDES YD Bio Limited Ordinary Shares | 6.36 | 0.1167 | -5350% | 13No options | 2 | $450M |
| ZBIO Zenas BioPharma, Inc. | 24.86 | - | - | 45Weak | 3 | $1.6B |
| ZEOX Zeo ScientifiX, Inc. | 0.9000 | - | - | 31No options | 5 | $7M |
| ZIVO ZIVO Bioscience, Inc. | 6.51 | 0.5254 | -1139% | 13No options | 2 | $25M |
| ZLAB Zai Lab Limited | 22.50 | - | - | 45Weak | 2 | $2.5B |
| ZNTL Zentalis Pharmaceuticals, Inc. | 2.32 | - | - | 33Weak | 2 | $165M |
| ZURA Zura Bio Limited | 4.41 | 1.15 | -284% | 26Weak | 2 | $423M |
| ZVRA Zevra Therapeutics, Inc. | 10.23 | 27.02 | +62% | 70Good | 6 | $607M |
| ZYME Zymeworks Inc. | 24.77 | - | - | 45Weak | 2 | $1.8B |
Drug Manufacturers - General (19)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ABBV AbbVie Inc. | 283.38 | 103.06 | -175% | 65Good | 9 | $500.8B |
| AMGN Amgen Inc. | 434.03 | 330.55 | -31% | 65Good | 8 | $234.7B |
| AMRN Amarin Corporation plc | 11.57 | 49.88 | +77% | 45Weak | 3 | $239M |
| AZN AstraZeneca PLC | 166.68 | 184.44 | +10% | 85Prime | 8 | $258.5B |
| BIIB Biogen Inc. | 235.35 | 197.03 | -19% | 58Fair | 4 | $34.8B |
| BMY Bristol-Myers Squibb Company | 60.57 | 76.74 | +21% | 86Prime | 7 | $123.7B |
| GILD Gilead Sciences, Inc. | 157.37 | 138.25 | -14% | 45Weak | 5 | $195.1B |
| GRFS Grifols, S.A. | 7.54 | 19.23 | +61% | 83Prime | 7 | $6.4B |
| GSK GSK plc | 49.02 | 43.72 | -12% | 70Good | 8 | $98.2B |
| JNJ Johnson & Johnson | 253.28 | 139.73 | -81% | 54Fair | 6 | $610.4B |
| LLY Eli Lilly and Company | 1,251.61 | 720.47 | -74% | 71Good | 8 | $1.18T |
| MIRA MIRA Pharmaceuticals, Inc. | 0.6581 | 0.2630 | -150% | 12No options | 2 | $28M |
| MRK Merck & Co., Inc. | 145.35 | 69.51 | -109% | 59Fair | 5 | $358.6B |
| NVO Novo Nordisk A/S | 39.22 | 173.67 | +77% | 91Prime | 6 | $174.9B |
| NVS Novartis AG | 150.38 | 144.89 | -4% | 68Good | 6 | $285.8B |
| OGN Organon & Co. | 13.76 | 18.60 | +26% | 66Good | 6 | $3.6B |
| PFE Pfizer Inc. | 29.21 | 19.78 | -48% | 58Fair | 7 | $166.5B |
| SCLX Scilex Holding Company | 2.85 | - | - | 22No options | 2 | $24M |
| SNY Sanofi | 39.77 | 63.49 | +37% | 86Prime | 7 | $97.4B |
Drug Manufacturers - Specialty & Generic (76)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| AAWH Ascend Wellness Holdings, Inc. | 0.4050 | 4.17 | +90% | 39No options | 4 | $82M |
| ACB Aurora Cannabis Inc. | 4.10 | - | - | 45Weak | 2 | $260M |
| AKAN Akanda Corp. | 1.31 | - | - | 19No options | 1 | $3M |
| ALKS Alkermes plc | 40.10 | 22.14 | -81% | 56Fair | 4 | $6.7B |
| ALVO Alvotech | 5.31 | - | - | 33No options | 0 | $1.9B |
| AMPH Amphastar Pharmaceuticals, Inc. | 26.42 | 45.40 | +42% | 77Good | 6 | $1.1B |
| AMRX Amneal Pharmaceuticals, Inc. | 19.25 | 12.43 | -55% | 57Fair | 7 | $6.1B |
| ANIP ANI Pharmaceuticals, Inc. | 72.28 | 243.25 | +70% | 77Good | 7 | $1.7B |
| AQST Aquestive Therapeutics, Inc. | 4.06 | - | - | 45Weak | 3 | $510M |
| AYTU Aytu BioPharma, Inc. | 2.01 | 5.29 | +62% | 39No options | 4 | $22M |
| BGM BGM Group Ltd. | 8.59 | 6.82 | -26% | 7No options | 0 | $109M |
| BHC Bausch Health Companies Inc. | 6.31 | 134.93 | +95% | 45Weak | 6 | $2.4B |
| BIOE Bio Essence Corporation | 0.3300 | 0.8646 | +62% | 39No options | 6 | $13M |
| CABR Caring Brands, Inc. | 1.29 | 0.1461 | -781% | 10No options | 0 | $12M |
| CGC Canopy Growth Corporation | 0.7355 | - | - | 37Weak | 4 | $311M |
| COLL Collegium Pharmaceutical, Inc. | 23.18 | 147.77 | +84% | 74Good | 5 | $755M |
| CPHI China Pharma Holdings, Inc. | 0.7279 | - | - | 32No options | 3 | $31M |
| CPIX Cumberland Pharmaceuticals Inc. | 7.54 | 22.07 | +66% | 45Weak | 3 | $113M |
| CRDL Cardiol Therapeutics Inc. | 1.15 | 0.1478 | -678% | 21Weak | 2 | $139M |
| CRON Cronos Group Inc. | 3.20 | 2.96 | -8% | 58Fair | 5 | $1.2B |
| DERM Journey Medical Corporation | 5.13 | - | - | 37Weak | 4 | $145M |
| EBS Emergent BioSolutions Inc. | 7.18 | 24.93 | +71% | 45Weak | 6 | $368M |
| EGRX Eagle Pharmaceuticals, Inc. | 0.1100 | 63.57 | +100% | 39No options | 4 | $1M |
| ELAN Elanco Animal Health Incorporated | 23.54 | 11.45 | -106% | 45Weak | 5 | $11.8B |
| ELTP Elite Pharmaceuticals, Inc. | 0.2500 | 6.20 | +96% | 39No options | 5 | $269M |
| EOLS Evolus, Inc. | 7.57 | 8.80 | +14% | 45Weak | 3 | $500M |
| ETON Eton Pharmaceuticals, Inc. | 51.33 | 15.29 | -236% | 52Fair | 7 | $1.5B |
| EVO Evotec SE | 1.42 | - | - | 29No options | 4 | $504M |
| GELS Gelteq Limited Ordinary Shares | 0.4306 | - | - | 29No options | 4 | $4M |
| GLAS Glass House Brands Inc | 3.71 | 54.67 | +93% | 45Weak | 0 | $326M |
| HCM HUTCHMED (China) Limited | 13.94 | 2.93 | -376% | 42Weak | 6 | $2.4B |
| HLN Haleon plc | 9.94 | 6.22 | -60% | 69Good | 8 | $43.7B |
| HROW Harrow Health, Inc. | 28.75 | 4.96 | -480% | 42Weak | 4 | $1.1B |
| HSTI High Sierra Technologies, Inc. | 1.40 | - | - | 28No options | 3 | $29M |
| HYEX Healthy Extracts Inc. | 1.05 | 0.6122 | -72% | 16No options | 3 | $15M |
| IMCC IM Cannabis Corp. | 1.33 | - | - | 24No options | 3 | $803K |
| INCR InterCure Ltd. | 4.65 | 6.18 | +25% | 45Weak | 4 | $55M |
| INDV Indivior Pharmaceuticals Inc | 33.62 | 56.88 | +41% | 75Good | 4 | $4.2B |
| INM InMed Pharmaceuticals Inc. | 1.33 | - | - | 26No options | 2 | $7M |
| IRWD Ironwood Pharmaceuticals, Inc. | 3.77 | 12.28 | +69% | 69Good | 7 | $623M |
| KMDA Kamada Ltd. | 7.83 | 14.12 | +45% | 67Good | 6 | $452M |
| LFCR Lifecore Biomedical, Inc. | 6.44 | - | - | 45Weak | 4 | $244M |
| LNTH Lantheus Holdings, Inc. | 99.99 | 183.99 | +46% | 60Fair | 5 | $6.5B |
| NIKA Nika Pharmaceuticals Inc. | 0.4100 | 0.0000 | -22736543% | 15No options | 2 | $430M |
| OGI Organigram Global Inc. | 0.9316 | 13.02 | +93% | 55Fair | 5 | $131M |
| OPTH Optimi Health Corp. | 3.19 | - | - | 26No options | 3 | $18M |
| ORGO Organogenesis Holdings Inc. | 1.11 | 4.16 | +73% | 45Weak | 2 | $143M |
| PAHC Phibro Animal Health Corporation | 37.93 | 43.87 | +14% | 72Good | 6 | $1.5B |
| PCRX Pacira BioSciences, Inc. | 36.40 | 39.44 | +8% | 63Fair | 8 | $1.5B |
| PCYN Procyon Corporation | 0.2700 | 0.1965 | -37% | 15No options | 2 | $2M |
| PLNH Planet 13 Holdings Inc. | 0.1100 | 0.1486 | +26% | 37No options | 3 | $37M |
| PRFX PRF Technologies Ltd. | 0.8188 | 6.39 | +87% | 39No options | 3 | $66K |
| PRGO Perrigo Company plc | 15.95 | 37.60 | +58% | 45Weak | 5 | $2.2B |
| RAPH Raphael Pharmaceutical Inc. | 1.40 | - | - | 21No options | 1 | $28M |
| RDHL RedHill Biopharma Ltd. | 0.4862 | - | - | 23No options | 3 | $2M |
| RDY Dr. Reddy's Laboratories Limited | 12.75 | 153.50 | +92% | 82Prime | 5 | $10.6B |
| RGC Regencell Bioscience Holdings Limited | 8.11 | 0.0281 | -28765% | 25Weak | 1 | $4.0B |
| RMTI Rockwell Medical, Inc. | 7.66 | 9.84 | +22% | 38Weak | 5 | $31M |
| SBFM Sunshine Biopharma, Inc. | 0.2430 | - | - | 34No options | 2 | $516K |
| SHPH Shuttle Pharmaceuticals Holdings, Inc. | 5.24 | - | - | 25No options | 1 | $25M |
| SIGA SIGA Technologies, Inc. | 3.10 | 8.72 | +64% | 45Weak | 1 | $223M |
| SNOA Sonoma Pharmaceuticals, Inc. | 1.16 | - | - | 30No options | 4 | $6M |
| SUPN Supernus Pharmaceuticals, Inc. | 40.18 | 46.46 | +14% | 45Weak | 3 | $2.3B |
| TAK Takeda Pharmaceutical Company Limited | 19.01 | 1,108.41 | +98% | 82Prime | 5 | $60.3B |
| TEVA Teva Pharmaceutical Industries Limited | 40.72 | 21.81 | -87% | 59Fair | 7 | $47.5B |
| TKNO Alpha Teknova, Inc. | 7.79 | - | - | 42Weak | 3 | $418M |
| TLPH Talphera, Inc. | 1.06 | - | - | 32Weak | 3 | $55M |
| TLRY Tilray Brands, Inc. | 3.14 | - | - | 45Weak | 4 | $351M |
| TRLV Trulieve Cannabis Corp. | 9.97 | 27.65 | +64% | 45Weak | 5 | $1.7B |
| TXMD TherapeuticsMD, Inc. | 1.97 | 5.39 | +63% | 45Weak | 4 | $23M |
| UPC Universe Pharmaceuticals Inc. | 4.15 | 7,380.95 | +100% | 38No options | 2 | $3M |
| VRNO Verano Holdings Corp | 5.14 | 41.44 | +88% | 39No options | 4 | $376M |
| VTRS Viatris Inc. | 17.44 | 18.82 | +7% | 45Weak | 7 | $20.0B |
| YCBD cbdMD, Inc. | 0.3530 | - | - | 20No options | 1 | $4M |
| ZTS Zoetis Inc. | 75.34 | 95.52 | +21% | 89Prime | 7 | $31.6B |
| ZYBT Zhengye Biotechnology Holding Limited | 1.53 | 10.85 | +86% | 36No options | 0 | $73M |
Medical - Care Facilities (61)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company, Inc. | 31.04 | 16.57 | -87% | 45Weak | 4 | $2.9B |
| ADUS Addus HomeCare Corporation | 116.49 | 115.55 | -1% | 67Good | 6 | $2.2B |
| AGL Agilon Health, Inc. | 88.45 | - | - | 37Weak | 3 | $1.5B |
| AIDX 20/20 Biolabs Inc. | 0.2751 | - | - | 30No options | 4 | $4M |
| AIRS AirSculpt Technologies, Inc. | 1.42 | - | - | 36Weak | 4 | $102M |
| AMN AMN Healthcare Services, Inc. | 40.00 | 75.98 | +47% | 81Prime | 8 | $1.5B |
| AMS American Shared Hospital Services | 1.26 | 6.91 | +82% | 39No options | 4 | $8M |
| AONC American Oncology Network, Inc. | 11.00 | - | - | 29No options | 3 | $322M |
| ARDT Ardent Health Inc. | 12.20 | 28.12 | +57% | 80Prime | 5 | $1.7B |
| ASTH Astrana Health, Inc. | 38.03 | 37.22 | -2% | 55Fair | 5 | $1.9B |
| AUNA Auna S.A. | 5.30 | 29.73 | +82% | 39No options | 6 | $392M |
| AVAH Aveanna Healthcare Holdings Inc. | 12.64 | 25.89 | +51% | 77Good | 5 | $2.8B |
| BICX BioCorRx Inc. | 0.2500 | - | - | 28No options | 3 | $7M |
| BKD Brookdale Senior Living Inc. | 10.09 | 8.23 | -23% | 45Weak | 6 | $2.4B |
| BMGL Basel Medical Group Ltd Ordinary Shares | 3.91 | - | - | 30No options | 0 | $6M |
| BTMD biote Corp. | 1.11 | 11.26 | +90% | 39No options | 7 | $49M |
| CCEL Cryo-Cell International, Inc. | 3.65 | 11.97 | +69% | 39No options | 6 | $29M |
| CCM Concord Medical Services Holdings Limited | 3.62 | - | - | 34No options | 6 | $524K |
| CHE Chemed Corporation | 515.44 | 334.59 | -54% | 58Fair | 7 | $6.7B |
| CON Concentra Group Holdings Parent, Inc. | 39.15 | 28.17 | -39% | 66Good | 8 | $5.0B |
| CYH Community Health Systems, Inc. | 2.99 | 154.27 | +98% | 45Weak | 5 | $422M |
| DCGO DocGo Inc. | 0.2820 | - | - | 40Weak | 3 | $28M |
| DVA DaVita Inc. | 189.16 | 301.75 | +37% | 82Prime | 7 | $12.1B |
| EHC Encompass Health Corporation | 127.77 | 114.09 | -12% | 72Good | 7 | $12.6B |
| ENSG The Ensign Group, Inc. | 178.11 | 134.74 | -32% | 59Fair | 7 | $10.4B |
| EUDA EUDA Health Holdings Limited | 15.49 | - | - | 31No options | 4 | $46M |
| FMS Fresenius Medical Care AG & Co. KGaA | 22.13 | 66.81 | +67% | 90Prime | 8 | $11.8B |
| FOXO FOXO Technologies Inc. | 0.1100 | 0.8043 | +86% | 39No options | 4 | $1M |
| GBCS Selectis Health, Inc. | 5.73 | 128.82 | +96% | 39No options | 4 | $18M |
| GMRS GMR Solutions Inc. | 10.39 | 26.59 | +61% | 38No options | 0 | $561M |
| GRDN Guardian Pharmacy Services, Inc. | 39.68 | 29.13 | -36% | 58Fair | 6 | $2.5B |
| HCA HCA Healthcare, Inc. | 468.50 | 599.99 | +22% | 86Prime | 7 | $101.4B |
| HCSG Healthcare Services Group, Inc. | 21.43 | 45.20 | +53% | 82Prime | 8 | $1.5B |
| HIMS Hims & Hers Health, Inc. | 29.38 | 55.91 | +47% | 45Weak | 2 | $6.6B |
| HLYK HealthLynked Corp. | 2.20 | - | - | 25No options | 3 | $6M |
| INNV Innovage Holding Corp. | 8.98 | 8.21 | -9% | 45Weak | 5 | $1.2B |
| JYNT The Joint Corp. | 6.91 | 4.08 | -69% | 38Weak | 8 | $98M |
| KJFI Comjoyful International Company | 0.9740 | - | - | 31No options | 4 | $212M |
| LFST LifeStance Health Group, Inc. | 12.37 | 8.21 | -51% | 63Fair | 8 | $4.7B |
| MD Pediatrix Medical Group, Inc. | 27.76 | 34.92 | +21% | 78Good | 7 | $2.3B |
| MNDR Mobile-health Network Solutions Class A Ordinary Shares | 1.09 | - | - | 33No options | 4 | $27K |
| NHC National HealthCare Corporation | 245.53 | 259.14 | +5% | 75Good | 8 | $3.8B |
| NIVF NewGenIvf Group Limited | 0.2500 | 18,221.66 | +100% | 39No options | 5 | $4K |
| NUTX Nutex Health, Inc. | 200.80 | 732.07 | +73% | 39No options | 6 | $1.4B |
| OPCH Option Care Health, Inc. | 31.22 | 36.30 | +14% | 70Good | 7 | $4.7B |
| PACS PACS Group, Inc. | 44.98 | 56.37 | +20% | 82Prime | 7 | $7.1B |
| PARK Park Dental Partners, Inc. Common Stock | 19.00 | 17,706.27 | +100% | 39No options | 5 | $90M |
| PIII P3 Health Partners Inc. | 4.37 | - | - | 24No options | 3 | $14M |
| PMHS Polomar Health Services, Inc. | 0.1250 | 0.0935 | -34% | 17No options | 3 | $4M |
| PNTG The Pennant Group, Inc. | 40.82 | 26.64 | -53% | 51Fair | 6 | $1.4B |
| RHEP Regional Health Properties, Inc. | 1.02 | 31,975.90 | +100% | 39No options | 6 | $4M |
| RHEPB Regional Health Properties, Inc. | 6.25 | 39,547.42 | +100% | 39No options | 6 | $11M |
| SGRY Surgery Partners, Inc. | 14.83 | 46.26 | +68% | 45Weak | 4 | $1.9B |
| SNDA Sonida Senior Living, Inc. | 35.79 | 112.02 | +68% | 45Weak | 3 | $1.7B |
| SRTA Strata Critical Medical, Inc. | 4.28 | 11.39 | +62% | 45Weak | 2 | $379M |
| STLN Starling Oncology, Inc. | 6.51 | - | - | 44Weak | 0 | $651M |
| SYRA Syra Health Corp. Class A Common Stock | 0.8430 | 0.2255 | -274% | 14No options | 5 | $10M |
| THC Tenet Healthcare Corporation | 271.60 | 729.27 | +63% | 88Prime | 7 | $21.9B |
| UHS Universal Health Services, Inc. | 185.89 | 441.31 | +58% | 91Prime | 8 | $11.0B |
| USPH U.S. Physical Therapy, Inc. | 84.91 | 50.56 | -68% | 45Weak | 5 | $1.3B |
| VMD Viemed Healthcare, Inc. | 9.69 | 14.75 | +34% | 77Good | 6 | $369M |
Medical - Devices (137)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | 104.69 | 67.26 | -56% | 62Fair | 5 | $181.2B |
| ADGM Adagio Medical Holdings, Inc. | 0.1030 | - | - | 30No options | 1 | $2M |
| AEMD Aethlon Medical, Inc. | 5.27 | 6.44 | +18% | 30No options | 1 | $3M |
| AHCO AdaptHealth Corp. | 6.39 | 34.79 | +82% | 45Weak | 5 | $871M |
| ALGN Align Technology, Inc. | 149.34 | 125.50 | -19% | 66Good | 7 | $10.6B |
| ALUR Allurion Technologies Inc. | 0.4750 | - | - | 27No options | 3 | $475K |
| AMIX Autonomix Medical, Inc. | 2.93 | 18.46 | +84% | 38No options | 2 | $2M |
| AORT Artivion, Inc. | 21.87 | 3.85 | -468% | 43Weak | 3 | $1.1B |
| ARAY Accuray Incorporated | 0.1738 | - | - | 37Weak | 2 | $21M |
| ATEC Alphatec Holdings, Inc. | 10.93 | 7.18 | -52% | 45Weak | 5 | $1.7B |
| AVHHL AVITA Medical, Inc. | 2.25 | - | - | 27No options | 3 | $304M |
| AVR Anteris Technologies Global Corp. | 6.36 | - | - | 45Weak | 3 | $620M |
| AXGN AxoGen, Inc. | 35.63 | 1.71 | -1982% | 40Weak | 4 | $2.1B |
| BBNX Beta Bionics, Inc. | 17.31 | - | - | 42Weak | 2 | $779M |
| BDMD Baird Medical Investment Holdings Limited | 0.6000 | 2.56 | +77% | 39No options | 3 | $19M |
| BFLY Butterfly Network, Inc. | 7.85 | - | - | 44Weak | 3 | $2.1B |
| BIO Bio-Rad Laboratories, Inc. | 364.82 | 246.29 | -48% | 58Fair | 7 | $9.8B |
| BJDX Bluejay Diagnostics, Inc. | 0.7793 | 10.79 | +93% | 39No options | 3 | $806K |
| BMRA Biomerica, Inc. | 1.88 | - | - | 23No options | 1 | $9M |
| BRKR Bruker Corporation | 56.54 | 18.80 | -201% | 45Weak | 5 | $8.6B |
| BRKRP Bruker Corporation | 417.62 | 27.00 | -1447% | 28No options | 5 | $8.6B |
| BSX Boston Scientific Corporation | 44.14 | 65.77 | +33% | 95Prime | 8 | $64.0B |
| BVS Bioventus Inc. | 13.81 | 26.25 | +47% | 73Good | 8 | $943M |
| CATX Perspective Therapeutics, Inc. | 2.34 | 0.1388 | -1585% | 22Weak | 3 | $267M |
| CBLL CeriBell, Inc. | 27.64 | - | - | 45Weak | 2 | $1.1B |
| CERS Cerus Corporation | 2.26 | 2.60 | +13% | 45Weak | 4 | $455M |
| CLPT ClearPoint Neuro, Inc. | 9.64 | - | - | 44Weak | 2 | $294M |
| CNMD CONMED Corporation | 47.14 | 79.07 | +40% | 82Prime | 8 | $1.4B |
| COCH Envoy Medical, Inc. | 0.6447 | 0.0239 | -2603% | 11No options | 3 | $50M |
| CTKB Cytek Biosciences, Inc. | 5.41 | 2.54 | -113% | 42Weak | 4 | $703M |
| CTSO Cytosorbents Corporation | 3.06 | - | - | 29Weak | 4 | $10M |
| CV CapsoVision, Inc. | 6.45 | - | - | 29No options | 2 | $343M |
| CVRX CVRx, Inc. | 1.39 | - | - | 36Weak | 3 | $37M |
| CYDX CYduct Diagnostics, Inc. | 0.5000 | 0.0180 | -2681% | 20No options | 5 | $3M |
| DCTH Delcath Systems, Inc. | 14.81 | 2.19 | -576% | 41Weak | 5 | $514M |
| DXCM DexCom, Inc. | 87.71 | 80.03 | -10% | 78Good | 8 | $33.1B |
| EBRCZ EBR Systems, Inc. | 0.1148 | - | - | 29No options | 4 | $73M |
| ECOR electroCore, Inc. | 8.35 | - | - | 28No options | 3 | $75M |
| ELMD Electromed, Inc. | 28.03 | 28.56 | +2% | 67Good | 7 | $232M |
| ENOV Enovis Corporation | 19.35 | 51.34 | +62% | 45Weak | 5 | $1.1B |
| ESMC Escalon Medical Corp. | 0.1800 | 32.38 | +99% | 39No options | 6 | $1M |
| ESTA Establishment Labs Holdings Inc. | 61.36 | - | - | 45Weak | 4 | $1.8B |
| EW Edwards Lifesciences Corporation | 88.10 | 39.75 | -122% | 62Fair | 6 | $50.8B |
| FOCL EDAP TMS S.A. American Depositary Shares | 4.13 | - | - | 43Weak | 4 | $155M |
| GCTK GlucoTrack, Inc. | 0.8319 | 102.02 | +99% | 35No options | 1 | $664K |
| GEHC GE HealthCare Technologies Inc. | 70.35 | 51.87 | -36% | 58Fair | 5 | $31.8B |
| GKOS Glaukos Corporation | 165.60 | - | - | 45Weak | 3 | $9.8B |
| GMED Globus Medical, Inc. | 78.84 | 112.94 | +30% | 92Prime | 7 | $10.6B |
| GTHP Guided Therapeutics, Inc. | 0.1900 | - | - | 27No options | 2 | $18M |
| HAE Haemonetics Corporation | 121.29 | 65.74 | -84% | 60Fair | 8 | $5.5B |
| HSCS HeartSciences Inc. | 3.18 | - | - | 21No options | 1 | $15M |
| HYPR Hyperfine, Inc. | 0.7801 | - | - | 42Weak | 4 | $71M |
| IART Integra LifeSciences Holdings Corporation | 13.53 | 11.25 | -20% | 45Weak | 5 | $1.1B |
| ICCM IceCure Medical Ltd | 1.04 | - | - | 32No options | 4 | $2M |
| INBS Intelligent Bio Solutions Inc. | 1.44 | - | - | 22No options | 3 | $5M |
| INFU InfuSystem Holdings, Inc. | 13.92 | 15.72 | +11% | 71Good | 9 | $277M |
| INGN Inogen, Inc. | 6.30 | - | - | 42Weak | 3 | $167M |
| INMD InMode Ltd. | 14.32 | 20.58 | +30% | 72Good | 5 | $824M |
| INSP Inspire Medical Systems, Inc. | 70.12 | 139.36 | +50% | 77Good | 7 | $2.0B |
| IRIX IRIDEX Corporation | 0.8244 | - | - | 33Weak | 3 | $14M |
| IRMD IRadimed Corporation | 89.37 | 44.42 | -101% | 48Weak | 5 | $1.1B |
| IRTC iRhythm Technologies, Inc. | 109.35 | 55.77 | -96% | 45Weak | 4 | $3.6B |
| ITGR Integer Holdings Corporation | 126.72 | 78.09 | -62% | 47Weak | 7 | $4.3B |
| IVF INVO Fertility, Inc. | 0.5910 | - | - | 27No options | 4 | $3M |
| KIDS OrthoPediatrics Corp. | 22.57 | 1.14 | -1883% | 44Weak | 5 | $589M |
| KLYG Kelyniam Global, Inc. | 0.1200 | - | - | 27No options | 3 | $6M |
| LFWD Lifeward Ltd. | 6.06 | - | - | 28Weak | 3 | $10M |
| LIVN LivaNova PLC | 78.50 | 99.67 | +21% | 82Prime | 8 | $4.3B |
| LMRI Lumexa Imaging Holdings, Inc. Common Stock | 10.78 | 7.46 | -45% | 30No options | 5 | $1.0B |
| LNSR LENSAR Inc | 6.03 | 61.47 | +90% | 57Fair | 5 | $74M |
| LUCD Lucid Diagnostics Inc. | 0.5201 | - | - | 36No options | 3 | $99M |
| LUNG Pulmonx Corporation | 1.85 | - | - | 36Weak | 3 | $79M |
| MBOT Microbot Medical Inc. | 0.9500 | 0.0728 | -1205% | 25Weak | 2 | $64M |
| MDT Medtronic Plc | 95.45 | 76.37 | -25% | 64Fair | 9 | $122.1B |
| MODD Modular Medical, Inc. | 2.16 | 2.46 | +12% | 34No options | 1 | $18M |
| MYO Myomo, Inc. | 1.30 | - | - | 31Weak | 2 | $51M |
| NEOG Neogen Corporation | 12.27 | 4.48 | -174% | 45Weak | 6 | $2.7B |
| NMTC NeuroOne Medical Technologies Corporation | 1.04 | - | - | 36Weak | 3 | $9M |
| NNOX Nano-X Imaging Ltd. | 0.4911 | - | - | 31Weak | 2 | $39M |
| NPCE NeuroPace, Inc. | 12.78 | - | - | 40Weak | 3 | $439M |
| NSPR InspireMD, Inc. | 0.4804 | - | - | 32Weak | 2 | $22M |
| NSYS Nortech Systems Incorporated | 10.32 | 15.29 | +33% | 39No options | 7 | $29M |
| NUWE Nuwellis, Inc. | 0.5532 | 2.34 | +76% | 39No options | 2 | $51K |
| NVCR Novocure Ltd | 14.41 | - | - | 45Weak | 5 | $1.7B |
| NVNO enVVeno Medical Corporation | 7.93 | 3.46 | -129% | 10No options | 1 | $6M |
| NXL Nexalin Technology, Inc. | 2.45 | - | - | 22No options | 3 | $2M |
| OFIX Orthofix Medical Inc. | 9.59 | - | - | 45Weak | 5 | $388M |
| OM Outset Medical, Inc. | 4.08 | - | - | 30Weak | 3 | $77M |
| OWLT Owlet, Inc. | 4.44 | - | - | 40Weak | 4 | $130M |
| PACB Pacific Biosciences of California, Inc. | 1.99 | - | - | 38Weak | 2 | $619M |
| PAVM PAVmed Inc. | 2.29 | - | - | 24No options | 2 | $15M |
| PEN Penumbra, Inc. | 320.12 | 139.38 | -130% | 54Fair | 5 | $12.6B |
| PETV PetVivo Holdings, Inc. | 0.7400 | - | - | 30No options | 4 | $28M |
| PFSA Profusa, Inc. Common Stock | 1.28 | - | - | 30No options | 2 | $1M |
| PHG Koninklijke Philips N.V. | 25.00 | 37.85 | +34% | 82Prime | 7 | $24.2B |
| PLSM Pulsenmore Ltd. Ordinary Shares | 1.82 | - | - | 32No options | 4 | $12M |
| PMI Picard Medical, Inc. | 12.68 | - | - | 33No options | 4 | $26M |
| POAS Phaos Technology Holdings (Caym | 2.43 | - | - | 14No options | 0 | $2M |
| PODD Insulet Corp. | 133.93 | 153.23 | +13% | 88Prime | 9 | $9.3B |
| POSC Positron Corporation | 1.50 | - | - | 22No options | 1 | $49M |
| PRCT PROCEPT BioRobotics Corporation | 17.51 | 44.96 | +61% | 45Weak | 2 | $997M |
| PROF Profound Medical Corp. | 6.62 | - | - | 45Weak | 3 | $242M |
| QSI Quantum-Si incorporated | 1.39 | 0.0998 | -1292% | 20Weak | 2 | $277M |
| QTI QT Imaging Holdings, Inc. | 2.50 | - | - | 32No options | 5 | $37M |
| QTRX Quanterix Corporation | 3.06 | - | - | 37Weak | 2 | $145M |
| RCEL Avita Medical Inc. | 13.10 | - | - | 43Weak | 3 | $325M |
| RPID Rapid Micro Biosystems, Inc. | 0.8173 | - | - | 24No options | 2 | $37M |
| RTGN RetinalGenix Technologies Inc. | 3.99 | - | - | 25No options | 2 | $75M |
| RXST RxSight, Inc. | 4.52 | - | - | 43Weak | 2 | $188M |
| SENS Senseonics Holdings, Inc. | 8.10 | - | - | 45Weak | 3 | $428M |
| SERA Sera Prognostics, Inc. | 2.07 | - | - | 32Weak | 3 | $80M |
| SGHT Sight Sciences, Inc. | 8.25 | 1.60 | -415% | 22Weak | 4 | $454M |
| SIBN SI-BONE, Inc. | 19.47 | 36.89 | +47% | 45Weak | 5 | $873M |
| SINT Sintx Technologies, Inc. | 1.82 | - | - | 27No options | 3 | $12M |
| SNN Smith & Nephew plc | 27.88 | 37.94 | +27% | 90Prime | 8 | $11.7B |
| SNWV SANUWAVE Health Inc. | 5.14 | 34.46 | +85% | 39No options | 4 | $44M |
| SONX Sonendo, Inc. | 1.28 | - | - | 31No options | 5 | $547K |
| SRTS Sensus Healthcare, Inc. | 2.86 | 3.03 | +6% | 36Weak | 2 | $47M |
| SSII SS Innovations International, Inc. | 2.70 | - | - | 26No options | 1 | $541M |
| STIM Neuronetics, Inc. | 1.89 | - | - | 38Weak | 3 | $144M |
| STME Stimcell Energetics, Inc. | 0.2300 | - | - | 19No options | 1 | $5M |
| SYK Stryker Corporation | 281.63 | 211.44 | -33% | 68Good | 8 | $108.0B |
| TCMD Tactile Systems Technology, Inc. | 22.41 | 40.62 | +45% | 75Good | 8 | $508M |
| TELA TELA Bio, Inc. | 1.10 | 1.19 | +8% | 36Weak | 3 | $49M |
| TLSI TriSalus Life Sciences, Inc. | 3.90 | - | - | 33Weak | 2 | $240M |
| TMCI Treace Medical Concepts, Inc. | 4.04 | - | - | 37Weak | 2 | $263M |
| TMDX TransMedics Group, Inc. | 75.52 | 116.64 | +35% | 68Good | 4 | $2.6B |
| TNDM Tandem Diabetes Care, Inc. | 16.01 | - | - | 45Weak | 3 | $1.1B |
| TNON Tenon Medical, Inc. | 2.82 | - | - | 30No options | 3 | $1M |
| UFPT UFP Technologies, Inc. | 291.10 | 250.97 | -16% | 65Good | 7 | $2.3B |
| USAQ QHSLab, Inc. | 0.4600 | 1.13 | +59% | 39No options | 5 | $7M |
| VNRX VolitionRX Ltd | 0.1790 | - | - | 39Weak | 3 | $2M |
| VREX Varex Imaging Corporation | 18.39 | 11.87 | -55% | 50Fair | 6 | $781M |
| VVOS Vivos Therapeutics, Inc. | 0.1340 | - | - | 27No options | 3 | $2M |
| XAIR Beyond Air, Inc. | 2.10 | 12.11 | +83% | 39No options | 4 | $1M |
| XTNT Xtant Medical Holdings, Inc. | 0.3185 | 0.2440 | -31% | 16No options | 3 | $45M |
| ZBH Zimmer Biomet Holdings, Inc. | 91.77 | 134.51 | +32% | 87Prime | 7 | $17.5B |
Medical - Diagnostics & Research (44)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| A Agilent Technologies, Inc. | 175.55 | 72.05 | -144% | 62Fair | 6 | $49.5B |
| ADVB Advanced Biomed Inc. Common Stock | 4.88 | 3.31 | -48% | 17No options | 2 | $8M |
| BDSX Biodesix, Inc. | 24.71 | - | - | 30No options | 4 | $201M |
| BIAF bioAffinity Technologies, Inc. | 3.96 | - | - | 28No options | 3 | $25M |
| BIOQ Bioqual, Inc. | 33.00 | 21.90 | -51% | 18No options | 4 | $30M |
| BLLN BillionToOne, Inc. | 102.73 | 191.05 | +46% | 81Prime | 7 | $4.8B |
| BNR Burning Rock Biotech Limited | 15.60 | - | - | 30No options | 3 | $17M |
| CDNA CareDx, Inc | 66.68 | 58.58 | -14% | 54Fair | 7 | $3.4B |
| CRL Charles River Laboratories International, Inc. | 306.24 | 137.46 | -123% | 45Weak | 5 | $14.8B |
| CSTL Castle Biosciences, Inc. | 33.80 | 4.68 | -622% | 38Weak | 3 | $1.0B |
| DGX Quest Diagnostics Incorporated | 239.01 | 149.02 | -60% | 58Fair | 7 | $26.4B |
| DHR Danaher Corporation | 231.50 | 103.75 | -123% | 61Fair | 6 | $162.7B |
| FLGT Fulgent Genetics, Inc. | 21.34 | 4.31 | -395% | 41Weak | 5 | $587M |
| GH Guardant Health, Inc. | 165.88 | - | - | 45Weak | 4 | $22.3B |
| GRAL GRAIL Inc. | 135.46 | - | - | 45Weak | 4 | $6.1B |
| ICLR ICON Public Limited Company | 175.13 | 140.71 | -24% | 61Fair | 7 | $13.5B |
| IDXG Interpace Biosciences, Inc. | 5.27 | 105.34 | +95% | 39No options | 5 | $31M |
| IDXX IDEXX Laboratories, Inc. | 547.18 | 377.99 | -45% | 70Good | 9 | $43.1B |
| ILMN Illumina, Inc. | 267.93 | 113.15 | -137% | 58Fair | 6 | $40.5B |
| IMDX Insight Molecular Diagnostics Inc. | 3.06 | - | - | 28Weak | 1 | $100M |
| IQV IQVIA Holdings Inc. | 271.04 | 193.82 | -40% | 65Good | 7 | $44.6B |
| ISPC iSpecimen Inc. | 1.03 | - | - | 23No options | 2 | $3M |
| LDDD Longduoduo Company Limited | 0.5100 | - | - | 23No options | 1 | $15M |
| LH Labcorp Holdings Inc. | 325.07 | 187.71 | -73% | 56Fair | 8 | $26.4B |
| MDXH MDxHealth S.A. | 0.6036 | - | - | 35No options | 4 | $58M |
| MEDP Medpace Holdings, Inc. | 628.60 | 504.82 | -25% | 65Good | 7 | $17.5B |
| MTD Mettler-Toledo International Inc. | 1,639.04 | 647.54 | -153% | 60Fair | 7 | $32.8B |
| MYGN Myriad Genetics, Inc. | 4.35 | - | - | 45Weak | 4 | $416M |
| NDRA ENDRA Life Sciences Inc. | 5.10 | - | - | 26No options | 2 | $8M |
| NEO NeoGenomics, Inc. | 17.25 | - | - | 45Weak | 4 | $2.2B |
| NTRA Natera, Inc. | 404.79 | 8.14 | -4874% | 45Weak | 3 | $58.3B |
| OPK OPKO Health, Inc. | 1.61 | 0.1839 | -776% | 40Weak | 2 | $1.2B |
| PRPO Precipio, Inc. | 22.25 | 9.87 | -125% | 21No options | 5 | $40M |
| PSNL Personalis, Inc. | 15.90 | - | - | 45Weak | 1 | $1.7B |
| QGEN Qiagen N.V. | 45.56 | 34.12 | -34% | 62Fair | 7 | $9.4B |
| QUCY Quantum Cyber N.V. | 1.03 | - | - | 28No options | 3 | $23M |
| RDNT RadNet, Inc. | 69.16 | 9.51 | -627% | 45Weak | 4 | $5.4B |
| RVTY Revvity, Inc. | 152.17 | 53.29 | -186% | 62Fair | 8 | $17.0B |
| SHC Sotera Health Company | 17.73 | 10.67 | -66% | 58Fair | 7 | $5.1B |
| TMO Thermo Fisher Scientific Inc. | 673.20 | 281.12 | -139% | 65Good | 6 | $248.9B |
| VCYT Veracyte, Inc. | 43.51 | 40.63 | -7% | 58Fair | 7 | $3.5B |
| WAT Waters Corporation | 436.91 | 85.55 | -411% | 57Fair | 5 | $42.9B |
| WGS GeneDx Holdings Corp. | 68.61 | - | - | 43Weak | 3 | $2.0B |
| XGN Exagen Inc. | 8.42 | - | - | 43Weak | 3 | $204M |
Medical - Distribution (13)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ACH Accendra Health, Inc. | 0.2615 | - | - | 36Weak | 2 | $20M |
| AHG Akso Health Group | 1.35 | - | - | 29No options | 3 | $1.2B |
| AIXN AiXin Life International, Inc. | 0.2600 | - | - | 27No options | 2 | $6M |
| CAH Cardinal Health, Inc. | 253.71 | 343.24 | +26% | 88Prime | 7 | $58.7B |
| COR Cencora, Inc. | 341.41 | 400.52 | +15% | 82Prime | 7 | $65.2B |
| EXHI Exlites Holdings International, Inc. | 0.4500 | - | - | 26No options | 2 | $20M |
| HKPD Cellyan Biotechnology Co., Ltd | 0.1099 | 0.3564 | +69% | 39No options | 4 | $5M |
| HSIC Henry Schein, Inc. | 86.99 | 63.41 | -37% | 56Fair | 6 | $9.7B |
| MCK McKesson Corporation | 998.64 | 833.66 | -20% | 65Good | 7 | $116.4B |
| MEDS DataMEDS AI, Inc. | 2.85 | - | - | 24No options | 1 | $7M |
| PDRX PD-Rx Pharmaceuticals, Inc. | 3.10 | 6.80 | +54% | 29No options | 0 | $5M |
| RDGT Ridgetech, Inc. | 0.8402 | 312.83 | +100% | 39No options | 4 | $755K |
| YI 111, Inc. | 3.11 | - | - | 26No options | 2 | $27M |
Medical - Equipment & Services (1)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| MMED MiniMed Group, Inc. | 18.00 | - | - | 45Weak | 3 | $5.1B |
Medical - Healthcare Information Services (44)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ACON Aclarion, Inc. | 1.95 | 20.69 | +91% | 38No options | 2 | $6M |
| AMWL American Well Corporation | 12.38 | - | - | 38Weak | 2 | $211M |
| BFRG Bullfrog AI Holdings, Inc. Common Stock | 0.5348 | 0.2125 | -152% | 21No options | 4 | $10M |
| BTSG BrightSpring Health Services, Inc. Common Stock | 62.36 | 46.43 | -34% | 59Fair | 7 | $12.3B |
| CARL Carlsmed, Inc. | 13.95 | 71.80 | +81% | 39No options | 4 | $381M |
| CCLD CareCloud, Inc. | 1.93 | 4.23 | +54% | 53Fair | 4 | $82M |
| CERT Certara, Inc. | 9.66 | 8.34 | -16% | 45Weak | 7 | $1.5B |
| CMPD CompuMed, Inc. | 6.30 | 7.16 | +12% | 39No options | 5 | $8M |
| CTEV Claritev Corporation | 23.86 | 120.21 | +80% | 45Weak | 5 | $404M |
| DH Definitive Healthcare Corp. | 0.9961 | 5.68 | +82% | 45Weak | 6 | $106M |
| DOCS Doximity, Inc. | 31.50 | 25.03 | -26% | 60Fair | 6 | $5.6B |
| EBYH Strainsforpains, Inc. | 0.2480 | - | - | 24No options | 1 | $3M |
| EVH Evolent Health, Inc. | 4.87 | 4.93 | +1% | 45Weak | 5 | $548M |
| GDRX GoodRx Holdings, Inc. | 3.51 | 3.44 | -2% | 62Fair | 7 | $1.2B |
| HCAT Health Catalyst, Inc. | 1.80 | 4.95 | +64% | 45Weak | 5 | $135M |
| HCTI Healthcare Triangle, Inc. | 0.4173 | - | - | 27No options | 2 | $6M |
| HNGE Hinge Health, Inc. | 104.96 | 61.09 | -72% | 57Fair | 6 | $8.5B |
| HQY HealthEquity, Inc. | 92.51 | 144.55 | +36% | 88Prime | 8 | $7.7B |
| HSTM HealthStream, Inc. | 33.75 | 23.38 | -44% | 56Fair | 7 | $1.0B |
| HTFL Heartflow, Inc. Common Stock | 50.91 | - | - | 45Weak | 4 | $4.4B |
| LFMD LifeMD, Inc. | 2.46 | - | - | 45Weak | 4 | $119M |
| LFMDP LifeMD, Inc. | 22.41 | - | - | 24No options | 2 | $153M |
| MDRX Veradigm Inc. | 5.00 | - | - | 37No options | 5 | $851M |
| MGRX Mangoceuticals, Inc. | 0.3210 | 0.0685 | -368% | 18No options | 3 | $7M |
| NRC NRC Health | 21.11 | 8.64 | -144% | 47Weak | 6 | $467M |
| OMCL Omnicell, Inc. | 35.95 | 23.57 | -52% | 53Fair | 8 | $1.6B |
| OMDA Omada Health | 18.67 | 4.09 | -357% | 52Fair | 7 | $1.1B |
| ONMD OneMedNet Corporation | 4.75 | - | - | 25No options | 2 | $28M |
| OPRX OptimizeRx Corp. | 8.85 | 9.80 | +10% | 62Fair | 7 | $167M |
| PHR Phreesia, Inc. | 10.63 | 14.46 | +26% | 68Good | 4 | $657M |
| PRVA Privia Health Group, Inc. | 21.67 | 42.94 | +50% | 45Weak | 2 | $2.8B |
| RVRC Revium Recovery Inc. | 1.43 | 0.0234 | -6006% | 10No options | 0 | $87M |
| SOPH SOPHiA GENETICS S.A. | 7.06 | - | - | 45Weak | 2 | $601M |
| SPOK Spok Holdings, Inc. | 10.74 | 21.09 | +49% | 71Good | 6 | $224M |
| SY So-Young International Inc. | 2.45 | - | - | 45Weak | 3 | $320M |
| TDOC Teladoc Health, Inc. | 5.81 | 21.97 | +74% | 45Weak | 5 | $1.1B |
| TEM Tempus AI, Inc. | 68.32 | - | - | 45Weak | 3 | $12.0B |
| VASO Vaso Corporation | 0.2900 | 0.3935 | +26% | 39No options | 7 | $51M |
| VRHI Veri Medtech Holdings Inc. | 4.41 | 0.5753 | -667% | 20No options | 4 | $35M |
| VYND Vynleads, Inc. | 0.4098 | - | - | 19No options | 2 | $8M |
| WAY Waystar Holding Corp. | 26.87 | 38.90 | +31% | 85Prime | 5 | $5.2B |
| WLSS Welsis Corp. | 0.6000 | - | - | 23No options | 0 | $2M |
| WORX SCWorx Corp. | 2.14 | 2.59 | +17% | 39No options | 5 | $34M |
| ZCMD Zhongchao Inc. | 1.38 | 449.49 | +100% | 39No options | 4 | $24K |
Medical - Healthcare Plans (13)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ALHC Alignment Healthcare, Inc. | 8.15 | 10.28 | +21% | 70Good | 6 | $1.7B |
| CI Cigna Corporation | 298.81 | 611.26 | +51% | 90Prime | 8 | $79.0B |
| CLOV Clover Health Investments, Corp. | 4.68 | 2.86 | -63% | 40Weak | 3 | $2.5B |
| CNC Centene Corp. | 70.51 | 237.84 | +70% | 45Weak | 6 | $34.8B |
| CVS CVS Health Corp. | 92.58 | 112.66 | +18% | 80Prime | 7 | $118.4B |
| ELV Elevance Health Inc. | 428.43 | 452.33 | +5% | 81Prime | 8 | $92.9B |
| HUM Humana Inc. | 432.20 | 240.89 | -79% | 59Fair | 7 | $51.9B |
| MOH Molina Healthcare, Inc. | 212.50 | 398.47 | +47% | 45Weak | 5 | $11.1B |
| MRAI Marpai, Inc. | 3.19 | - | - | 20No options | 3 | $86M |
| OSCR Oscar Health, Inc. | 33.47 | 100.82 | +67% | 75Good | 6 | $8.7B |
| PFHO Pacific Health Care Organization, Inc. | 0.9400 | 2.03 | +54% | 39No options | 4 | $12M |
| PGNY Progyny, Inc. | 27.84 | 39.08 | +29% | 83Prime | 6 | $2.1B |
| UNH UnitedHealth Group Incorporated | 395.62 | 308.02 | -28% | 64Fair | 8 | $355.1B |
Medical - Instruments & Supplies (45)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ANGO AngioDynamics, Inc. | 11.58 | 1.22 | -853% | 45Weak | 5 | $487M |
| ATR AptarGroup, Inc. | 124.26 | 102.12 | -22% | 60Fair | 6 | $7.9B |
| ATRC AtriCure, Inc. | 57.78 | 12.55 | -361% | 58Fair | 8 | $2.9B |
| AVTR Avantor, Inc. | 16.09 | 17.57 | +8% | 45Weak | 5 | $10.9B |
| AZTA Azenta, Inc. | 36.52 | 10.35 | -253% | 45Weak | 4 | $1.6B |
| BAX Baxter International Inc. | 25.76 | 24.77 | -4% | 45Weak | 4 | $13.3B |
| BDX Becton, Dickinson and Company | 193.76 | 145.93 | -33% | 57Fair | 7 | $52.8B |
| BLCO Bausch + Lomb Corporation | 16.66 | 10.95 | -52% | 45Weak | 4 | $6.0B |
| BNGO Bionano Genomics, Inc. | 1.37 | - | - | 26No options | 4 | $16M |
| COO The Cooper Companies, Inc. | 57.40 | 51.06 | -12% | 65Good | 7 | $10.9B |
| CUPR Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | 1.95 | 0.3943 | -395% | 7No options | 0 | $5M |
| DXR Daxor Corporation | 10.20 | 42.03 | +76% | 39No options | 4 | $60M |
| EMBC Embecta Corp. | 6.45 | 35.51 | +82% | 74Good | 6 | $365M |
| FEMY Femasys Inc. | 1.74 | - | - | 24No options | 1 | $15M |
| HBIO Harvard Bioscience, Inc. | 8.31 | - | - | 32No options | 5 | $38M |
| ICUI ICU Medical, Inc. | 167.23 | 60.82 | -175% | 50Fair | 6 | $4.2B |
| ISRG Intuitive Surgical, Inc. | 427.86 | 228.86 | -87% | 68Good | 7 | $151.2B |
| KMTS Kestra Medical Technologies, Ltd. | 28.68 | - | - | 34No options | 2 | $1.7B |
| KRMD KORU Medical Systems, Inc. | 3.03 | 0.2707 | -1019% | 28Weak | 5 | $139M |
| LMAT LeMaitre Vascular, Inc. | 83.16 | 73.78 | -13% | 65Good | 6 | $1.9B |
| LUCY Lucyd, Inc | 0.8425 | - | - | 24No options | 3 | $7M |
| MDLN Medline Inc. | 36.57 | 37.97 | +4% | 80Prime | 8 | $32.1B |
| MLSS Milestone Scientific Inc. | 0.3267 | - | - | 32Weak | 3 | $30M |
| MMSI Merit Medical Systems, Inc. | 89.57 | 65.92 | -36% | 59Fair | 6 | $5.3B |
| NEPH Nephros, Inc. | 3.51 | 5.34 | +34% | 39No options | 4 | $38M |
| NNNN Anbio Biotechnology Class A Ordinary Shares | 3.30 | 5.39 | +39% | 39No options | 5 | $145M |
| NVST Envista Holdings Corp | 23.50 | 20.52 | -15% | 65Good | 8 | $3.8B |
| NXGL NEXGEL, Inc. | 5.18 | - | - | 24No options | 1 | $110K |
| OSUR OraSure Technologies, Inc. | 3.81 | 0.4612 | -726% | 38Weak | 4 | $263M |
| PDEX Pro-Dex, Inc. | 59.82 | 87.22 | +31% | 39No options | 7 | $193M |
| PLSE Pulse Biosciences, Inc. | 46.32 | 1.06 | -4275% | 38Weak | 3 | $3.3B |
| POCI Precision Optics Corporation, Inc. | 4.41 | - | - | 31No options | 5 | $48M |
| RGEN Repligen Corporation | 178.20 | 25.50 | -599% | 58Fair | 7 | $11.3B |
| RMD ResMed Inc. | 235.29 | 307.44 | +23% | 87Prime | 6 | $33.1B |
| RVP Retractable Technologies, Inc. | 0.5931 | 0.7365 | +19% | 37Weak | 2 | $18M |
| SMTI Sanara MedTech Inc. | 35.12 | 62.66 | +44% | 39No options | 5 | $323M |
| SOLV Solventum Corporation | 87.26 | 100.23 | +13% | 79Good | 7 | $14.9B |
| STAA STAAR Surgical Company | 21.84 | 2.47 | -783% | 45Weak | 4 | $1.1B |
| STVN Stevanato Group S.p.A. | 19.31 | 10.82 | -79% | 58Fair | 6 | $5.3B |
| STXS Stereotaxis, Inc. | 1.05 | - | - | 36Weak | 3 | $105M |
| TFX Teleflex Incorporated | 123.29 | 85.49 | -44% | 45Weak | 5 | $5.2B |
| UTMD Utah Medical Products, Inc. | 74.79 | 47.66 | -57% | 29No options | 7 | $237M |
| WST West Pharmaceutical Services, Inc. | 374.65 | 104.99 | -257% | 65Good | 8 | $26.4B |
| XRAY DENTSPLY SIRONA Inc. | 8.44 | 17.78 | +53% | 45Weak | 5 | $1.7B |
| ZJYL Jin Medical International Ltd. | 2.02 | 1.68 | -20% | 17No options | 3 | $16M |
Medical - Pharmaceuticals (25)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ADIA Adia Med Inc. | 0.1400 | 222.25 | +100% | 34No options | 0 | $13M |
| AJYG AJ1G, Inc. | 0.1037 | 0.0001 | -149449% | 2No options | 0 | $1M |
| ASBP Aspire Biopharma Holdings, Inc. | 8.64 | - | - | 32No options | 5 | $997K |
| BFRI Biofrontera Inc. | 0.8471 | - | - | 28No options | 2 | $13M |
| BGMS Bio Green Med Solution, Inc. | 0.8326 | 4.51 | +82% | 39No options | 4 | $5M |
| CNSY Cerenome, Inc. | 1.88 | 1.39 | -36% | 13No options | 2 | $14M |
| CORT Corcept Therapeutics Incorporated | 113.37 | 24.31 | -366% | 57Fair | 6 | $12.3B |
| COSM Cosmos Health Inc. | 0.3364 | - | - | 36Weak | 4 | $34M |
| CTOR Citius Oncology, Inc. | 0.7460 | 0.1046 | -613% | 9No options | 3 | $69M |
| GCAN Trafalgar International, Inc. | 1.60 | 108.10 | +99% | 38No options | 2 | $318K |
| GWLL Goldenwell Biotech, Inc. | 0.6000 | 0.0007 | -87122% | 3No options | 1 | $59M |
| HELP Helus Pharma Inc. | 11.05 | 3.18 | -248% | 28Weak | 3 | $685M |
| HITI High Tide Inc. | 2.56 | 5.54 | +54% | 45Weak | 2 | $228M |
| INBP Integrated BioPharma, Inc. | 0.1800 | 0.9275 | +81% | 37No options | 2 | $6M |
| KNSA Kiniksa Pharmaceuticals International, plc | 79.94 | 46.31 | -73% | 55Fair | 6 | $6.2B |
| LQDA Liquidia Corporation | 34.78 | 29.69 | -17% | 52Fair | 6 | $3.1B |
| NSRX Nasus Pharma Ltd. | 3.17 | 0.0567 | -5486% | 4No options | 2 | $27M |
| PAVS Paranovus Entertainment Technology Ltd. | 3.22 | 2,111.23 | +100% | 39No options | 3 | $3M |
| PBH Prestige Consumer Healthcare Inc. | 48.40 | 105.25 | +54% | 76Good | 5 | $2.3B |
| POM POMDOCTOR Ltd | 0.6429 | - | - | 19No options | 0 | $5M |
| RPRX Royalty Pharma plc | 58.99 | 64.00 | +8% | 76Good | 6 | $26.3B |
| RTEZ Rest Ez Inc. | 70.00 | 0.0327 | -213797% | 12No options | 0 | $4.2B |
| SCNX Scienture Holdings, Inc. | 3.35 | 1.00 | -234% | 12No options | 4 | $6M |
| SCYX SCYNEXIS, Inc. | 3.96 | - | - | 32Weak | 2 | $25M |
| SKVI Skinvisible, Inc. | 0.2026 | - | - | 21No options | 1 | $1M |
Medical - Specialties (20)
| Stock | Close | Fair value | MoS | Wheel | Health | Mkt cap |
|---|---|---|---|---|---|---|
| ALC Alcon Inc. | 66.58 | 49.52 | -34% | 68Good | 8 | $32.2B |
| ANIK Anika Therapeutics, Inc. | 20.69 | 2.47 | -737% | 40Weak | 5 | $277M |
| APYX Apyx Medical Corporation | 2.56 | - | - | 35Weak | 3 | $108M |
| BEAT HeartBeam, Inc. | 0.4315 | 0.1033 | -318% | 20No options | 2 | $24M |
| BWAY BrainsWay Ltd. | 11.82 | 8.13 | -45% | 33Weak | 6 | $464M |
| DRIO DarioHealth Corp. | 5.13 | 119.64 | +96% | 39No options | 3 | $50M |
| IDTA IDenta Corp. | 0.3500 | 0.5417 | +35% | 39No options | 6 | $1M |
| ITOC iTonic Holdings Ltd. | 4.01 | 0.5851 | -585% | 10No options | 2 | $27M |
| LAB Standard BioTools Inc. | 0.6584 | - | - | 36Weak | 3 | $258M |
| MASS 908 Devices Inc. | 11.89 | 0.2993 | -3872% | 32Weak | 3 | $491M |
| MDAI Spectral AI, Inc. | 1.54 | - | - | 24No options | 1 | $50M |
| MLAB Mesa Laboratories, Inc. | 127.74 | 45.24 | -182% | 28No options | 7 | $715M |
| MOBI Mobia Medical, Inc. Common Stock | 8.31 | - | - | 22No options | 0 | $277M |
| NYXH Nyxoah S.A. | 1.19 | - | - | 26No options | 2 | $121M |
| QDEL QuidelOrtho Corporation | 13.87 | - | - | 45Weak | 3 | $951M |
| SI Shoulder Innovations, Inc. | 17.87 | - | - | 26No options | 2 | $372M |
| SKIN SkinHealth Systems Inc. | 11.56 | 67.34 | +83% | 45Weak | 5 | $75M |
| STE STERIS plc | 217.26 | 214.59 | -1% | 80Prime | 8 | $21.2B |
| TRIB Trinity Biotech plc | 6.61 | - | - | 26Weak | 3 | $134M |
| WOK WORK Medical Technology Group Ltd. Class A | 1.35 | - | - | 29No options | 4 | $3M |
Screen Healthcare with your own rules
The Stocks scanner filters all 1,120 by fair value, health, moat, dividends, earnings dates and option liquidity, with the Sectors strip showing how Healthcare has moved. Free accounts get a preview; Pro gets the lot.
Start free All sectors